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Abstract
In the developing world haemolytic anaemia are becoming a huge disease burden. The
diagnostic tests are time consuming and costly as well.in our study we subjected the
patients with a clinical suspicion to basic panel of investigations to establish an
underlying haemolytic process  and tried to categorise  haemolytic anemia. Our panel
of simple investigations include CBC, peripheral blood smear, reticulocyte count,
osmotic fragility test, serum bilurubin, hemoglobinuria and hemosiderinuria. With
this panel  we were able to diagnose50% of cases as thalassaemia, 21.42% of caeses
as post haemolytic state,7.145 as haemolytic disease of new born and the remaining as
others in which an underlying haemolytic process was established.
Key words :
haemolytic anemia, thalassaemia, post haemolytic state, hemosiderinuria ,peripheral
smear
INTRODUCTION
Haemolytic anaemias account for a huge disease burden, particularly in the
developing world. And it is on the increase as more and more diseased children now
routinely survive into adulthood. Proper diagnosis and management are of paramount
importance.
Investigation of haemolytic anaemia involves three steps.
1. Establishing that it is haemolytic anaemia
2. Making a working diagnosis necessary for clinical management
3. Special  investigations for sub-typing, genotyping etc,
Haemolytic anaemia is a condition of decreased red cell survival in which the intact
regenerative capacity of marrow is unable to compensate for the accelerated loss.
When the production keeps pace with the destruction it is compensated haemolytic
state. It follows that, for establishing haemolytic anaemia we have to gather evidence
of increased destruction and also increased production.
Red cell survival and kinetic studies are the definitive means of establishing
haemolytic anaemia. However for all practical purposes, Anaemia, increased
unconjugated bilurubin and reticulocytosis are diagnostic. While the first two indicate
red cell destruction the third is indicative of increased production. Increased
urobilinogen in urine and the presence of polychromatic red cells in the smear are
other useful and simple indicators.
Splenomegaly is found in chronic cases, sickle cell anemia being an exception in that
the spleen usually shrinking this disease due to infarctions. Widening of dipole skull
and facial bones during childhood gives rise to typical features often described as
haemolytic facies. This is most marked in thalassemia major.
In India with majority of people in low socioeconomic strata, complete evaluation of
haemolytic anaemia will be of huge burden. A basic panel of tests will be of immense
use to classify or type haemolytic anaemia and directions for further work up. The
basic panel of tests like CBC, peripheral smear study, serum bilurubin,
hemoglobinuria, and hemosiderinuria will establish the diagnosis of haemolytic
anaemia and further aids in directions for specialised investigations like haemoglobin
electrophoresis, genetic and molecular studies. Osmotic fragility test will be of
definite use in diagnosing diseases like hereditary spherocytosis, thalassaemia and
sickle cell anaemia etc. along with other parameters like CBC and peripheral smear.
Majority of Immune haemolytic anaemias can be diagnosed using coomb’s tests
(direct and indirect).
Aims and objectives
1. To formulate a panel of basic screening tests for evaluation of haemolytic anaemia
2. To assess the age and sex distribution of various type of haemolytic anaemia
3. To assess the incidence of various types of haemolytic anaemia
REVIEW OF LITERATURE
Haemolytic anemias can be clinically classified into hereditary and acquired. It can be
classified based on the pathophysiology into intracapsular and extracapsular. In
general intracapsular haemolytic anemias in which the defect is to be found in the red
cell are hereditary whereas paroxysmal nocturnal hemoglobinuria is an exception. On
the other hand, the extracapsular haemolytic anemias  are almost always acquired.
More than 95% of all symptomatic haemolytic anemias belong to a handful of entities
in which the prevalence of chronic diseases like thalassemia and sickle cell anaemia
would be higher. There are millions of people with sickle cell anaemia and their
number are in increasing trend as life expectancy improves with better medical care.
G6PD despite the vast number of people having mutant genes poses problems only in
a few.
Table-1. Classification of Haemolytic anemias 1
Intracorpuscular defects Extracorpuscular factors
Hereditary Hemoglobinopathies Familial haemolytic uremic syndrome
Enzymopathies
Membrane-cytoskeletal defects
Acquired Paroxysmal nocturnal
hemoglobinuria
Mechanical destruction
(macroangiopathic)
Toxic agents
Drugs
Infectious
Autoimmune
Hemoglobinopathies include thalassaemias and sickle cell syndromes.
Enzymopathies incorporates G6PD (glucose -6-phosphate dehydrogenase) and
pyruvate kinase deficiencies. Membrane cytoskeletal defects are hereditary
spherocytosis, hereditary elliptocytosis, south asian ovalocytosis and
pyropoikilocytosis. The cumulative gene frequency of hemoglobinopathies in India
lies nearly to 4.2 per cent. This disease prevalence varies with the geographic
locations and racial populations. The research carried by The Indian Council of
Medical Research (ICMR) revealed six cities of six states results, and have worked
out that the overall incidence of beta thalassemia trait (BTT) was 2.78 per cent.2 In
another study from different parts of India have shown an incidence of beta
thalassemia to be 3-15 per cent.3-9. In Orissa7 HbS is very common whereas in West
Bengal the commonest hemoglobinopathy seen is HbE8,9 and thus this disease
incidence also differs in different parts of India. Whereas in Punjab (Hb D-Punjab)
shows greatest prevalence among Sikhs (2 %).9 The ICMR study showed that HbE
was mainly seen in Assam (23.9 per cent) and Kolkata in West Bengal (3.92 %).3 It is
well established that the incidence of HbE gene in the North Eastern region of India is
one of the highest incidence worldwide.11 Different states of the North Eastern region
show a variable incidence of HbE varying from 16.2 per cent to 47.3 per cent.12-14 A
huge migrant tea garden population also shows a high incidence of HbS.14,15Hb E
disease will present as variable clinical phenotypes viz. homozygous, heterozygous or
compound heterozygous forms.
The thalassaemias are a heterogeneous group of inherited disorders of
haemoglobin characterised by reduced or absent production of one (or rarely more) of
the globin chains. They are the commonest single gene disorders in the world. The
thalassaemias constitute a major public health problem in the countries surrounding
the Mediterranean and in the Middle and the Far East. Lack of standard medical care
and of regular and safe blood supply in some countries is associated with profound
morbidity and mortality from thalassaemias.  This is one of the prevalent monogenic
disorders in the Indian subcontinent. It is estimated that there are 30–40 million
carriers, and 8,000 to 10,000 thalassaemics are born every year in India.2 In contrast to
the global frequency of 1.5 % , the average carriers of β-thalassaemia trait (BTT) in
India comprise 3.3 per cent of the population. Though its presence is recorded from
different regions of India, the frequency varies widely between 0.5 and 17 per cent in
different geographical regions 2. Unlike β-thalassaemia, the distribution of sickle cell
anaemia (sickle cell haemoglobin (HbS) is restricted to specific geographic regions.
Two features are obvious from the studies done in northern India and North Eastern
states on α- and β-globin traits in India: the frequency of traits varies with region and
there is a significant gap in knowledge from regions like, Rajasthan, Bihar, Jharkhand,
Tamil Nadu, Kerala,UP etc. that comprise massive Indian population.
Sickle cell syndromes are present throughout the world. It has a high morbidity
and mortality index. It affects multiple organs because of the vasoocclusive
phenomenon.
In India, sickle cell trait is  found in the Veddian tribes19, the tribals of Western
India20 and  the labour tribes drawn from Orissa working in the Assam tea gardens has
been  reported. It is also present in a group of marathy speaking people of low socio
economic strata and in the people of Nagpur and surrounding districts.
First description of inherited disorder of hereditary spherocytosis was made in
the year 1871 and it was followed by the first splenectomy. In Northern Europe and
North America the commonest etiology for chronic hemolysis is HS.  The incidence
being  1 in5000 births .21 HS occurs in all races but has a high prevalence in people of
Northern European descent (1:5000). In our country, HS is found mainly in North
India.
Hereditary Eliptocytosis (HE) affects 3-5 per 10,000 people in the United
States22. It is prevalent in people of Mediterranean and African desendents. In India,
its frequency is highest among Sikhs of Punjab (3.6%).it is of low frequency in
Jammu & Kashmir (3.3%) and UP (2.3%). 23-25 HPP is most often found in those of
African desendents, whereas spherocytic HE is most often found in Caucasians, HE
seems to confer protection against malaria, particularly the SAO subtype, and its
prevalence can be much greater in areas of the world where malaria is endemic. The
majority of forms are transmitted in an autosomal dominant fashion except for HPP,
which is autosomal recessive.
HE characteristically present as oval or elliptical shaped RBCs on the
peripheral blood film. Mutations in membrane skeletal proteins that disrupt lateral
interaction and contacts with the overlying lipid bilayer are unaffected (unlike in
hereditary spherocytosis) most commonly, the mutations are in spectrin and result in
the inability of spectrin dimers to form oligomers. Mutations of alpha spectrin, beta
spectrin and protein 4.1 are responsible for 65%, 30%, and 5% of cases of hereditary
elliptocytosis respectively.26
There are five major subtypes viz., silent carriers, common HE (90 %),
hereditary pyropoikilocytosis (HPP), spherocytic HE (10 %), and South Eastern Asian
ovalocytosis (SAO).
Immune haemolytic anaemia (IHA) is an acquired type of haemolytic anemia.
The lysis of RBC occurs due to adherence of antibodies to the antigens present over
the surface of RBC.   Red cell lysis is mediated by the complement system and
macrophages OF RES.
There are three types of immune haemolytic anemia; 27
1.Auto immune
2.Aalloimmune
3. Drug induced
In Caucasians the incidence of  IHA  is 1 in 80,000 to 100,000 of  per year.28
The peak incidence of age is between 60 and 70 years.  Females are most commonly
affected (60%).29
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a hereditary
intrinsic enzyme defect, with about 400 million people affected worldwide and is
characterised by reduced activity of G6PD red cells, and haemolysis occurrs after
exposure to oxidant stress. More than 400 biochemical variants of G6PD have been
identified. The variants are grouped into five classes by World Health Organization
Scientific Working Group. Polymorphic mutations occur with high frequency in
malaria-endemic areas (WHO class II and III) and include G6PD A (common in
Africa) and G6PD Mediterranean (common in Mediterranean countries, Middle East,
and India). In such cases, haemolysis develops only following oxidant exposure.
Sporadic mutations occur anywhere in the world at low frequency and patient
develops chronic haemolytic anaemia (WHO class-I). The well-known abnormal
G6PD variants associated with G6PD deficiency are G6PD A (prevalent in Africa;
half life 13 days) and G6PD Mediterranean (half life several hours). G6PD variant
with normal enzyme activity is G6PD Β (half life 60 days). The deficient variants
common in India are namely Mediterranean, Kerala-Kalyan, and Orissa. India has a
diverse population and a recent review summarized G6PD prevalence across the
country as 0–10 per cent.  The prevalence of 6.17 % is concurrent with the prevalent
rate in India. 30,31
In males by using biochemical screening methods the prevalence of G6PD
deficiency was calculated. It was found to be in the range of 0–65 %. The Vataliya
Prajapati community has got the highest incidence and the prevalence is also high in
South and Western India. 30
Thalassaemias
Classification of  Thalassaemias
The classification of thalassaemias is based on the type of globin chain that is
deficiently synthesised, or clinical expression of the disease.
Classification according to the type of globin chain which is deficiently synthesised:
The two most common types are α (alpha) and β (beta) thalassaemias. Less
common types are δβ (delta beta) thalassaemia and γδβ (gamma-delta-beta)
thalassaemia. Classification according to clinical severity: β thalassaemias have been
clinically classified on the basis of severity of anaemia into three types viz.,
thalassaemia major, thalassaemia intermedia, and thalassaemia minor. Patients with
severe transfusion dependent anaemia are said to have thalassaemia major. In
thalassaemia minor, affected individuals are usually asymptomatic with mild or no
anaemia in spite of prominent red cell abnormalities in peripheral blood. Thalassaemia
intermedia is characterised by intermediate degree of severity of anaemia that does not
require regular blood transfusions. Each of these clinical types are genetically diverse.
Clinical types of α thalassaemia are Hb Bart’s hydrops foetalis syndrome, HbH
disease, α thalassaemia trait and silent carrier.
β-Thalassemias
β-Thalassemias are disorders caused by reduced synthesis of β-globin, encoded
by the β-globin locus on chromosome 11.  There are about 200 distinct causative
mutations.  Of these about 28 mutations have been documented in Indian patients, 32-
34; 80 % of cases can be attributed to 20 relatively common mutations. Most mutations
are single-base substitutions that decrease the activity of the β-globin promoter
activity or have deleterious effects on RNA processing/splicing/ translation .32
Deletions (common in α-thalassemia) are rare. Individuals inheriting one defective β-
globin allele typically have β-thalassemia major. Individuals inheriting two defective
β-globin alleles have β-thalassemia major (Cooley anemia) or β-thalassemia
intermedia, depending on the combination of alleles that are inherited.
α thalassaemias
α-Thalassemias are disorders caused by reduced synthesis of α-globin chains
that are generally due to inherited α-globin gene deletions. Normally, each copy of
chromosome 16 contains two closely linked α-globin genes, such that there are four
α-globin genes in the normal diploid state. Different forms of α-thalassemia of
increasing severity are caused by deletions that result in the loss of one to four
α-globin loci.35α-thalassemia minima with loss of one α-globin locus with virtually no
clinical or laboratory findings. α-thalassemia minor with loss of two α-globin loci
presents with microcytosis, hypochromasia, and mild anemia.  HbH disease with loss
of three α-globin loci marked by the presence of β4 hemoglobin (hemoglobin H,
composed of a β-globin tetramer). Presents in infancy with jaundice, splenomegaly,
and moderate microcytic hypochromic anemia.36Hydrops fetalis with loss of four α-
globin loci results in death in utero or immediately after birth. Most haemoglobin
consists of Hb Barts, a tetramer composed of fetal hemoglobin (γ4) that has such high
O2 affinity that it releases little O2 to tissues.37
Hemoglobin C disease
This hemoglobinopathy is caused by HbC. It is produced by a mutation that
results by shifting of glutamic acid with lysine at sixth position of β-globin. HbC is
prone to polymerize into characteristic crystals and also results in increase of
potassium or chloride co-transport, leading to cellular dehydration and slightly
decreased red cell survival HbC trait is asymptomatic without anaemia. HbC disease
is often asymptomatic but can result in mild hemolytic anaemia and splenomegaly.
Compound HbC/HbS heterozygosity produces a sickling syndrome. It has that fall in
between the entities namely sickle cell trait and sickle cell disease.
Hemoglobin E disease
It is caused as result of glutamic acid to lysine substitution at twenty sixth
position of  of beta-globin,38which creates an alternative splice site, when this splice
site is used, an abnormal unstable mRNA is produced, resulting in a net reduction in
β-globin synthesis and a thalassemia-like phenotype.
Sickle cell syndromes
The sickle cell syndromes are a group of haemolytic anemias which are due to
a mutation in the beta-globin gene. The glutamic acid at the sixth position is switched
with valine. When deoxygenation occurs haemoglobin S α2β2(6Glu→Va l 20) undergo
sickled shape.17,18
Because of the sickled shape the cells while passing through small capillaries and
venules will stick to the endothelium. This will lead to vaso-occlusion and hemolysis.
The spleen is the site of destruction of abnormal RBCs. This vaso-occlusion is cause
for ischaemic  episodes  and end organ damage.18
The clinical manifestations of sickle cell syndromes are primarily due to vaso-
occlusive episodes. These vaso-occlusive episodes can happen in any one of the organ
systems like brain, kidney, lung etc. Patient will be presenting with excruciating pain
pertaining to the affected organ (painful crises).  There are multiple patterns of
inheritance of HbS i.e a hemoglobinopathy and from one parent and HbC (α2β2
6Glu→Lys) another parent.
Affected individual will have a haemolytic picture, with a PCV of 15–30 %
and reticulocytosis. Initially, it was thought that anaemia will counteract the
vasoocclusion by reducing blood viscosity. Granulocytosis is common. Fluctuation of
total WBC count is seen and it can be unpredictable during episodes of acute illnesses.
The manifestations of vaso-occlusion are diverse. Sickle cell anaemia can be
diagnosed based on the peripheral blood film with other laboratory parameters
supporting an underlying haemolytic process viz, reticulocytosis, increased UCB and
decreased serum haptoglobin etc along with intermittent episodes of ischemic pain.
Hereditary spherocytosis
Hereditary spherocytosis (HS) is a congenital haemolytic disorder characterised
by an inherited defect in the RBC membrane cytoskeleton and causes the formation of
spherocytic red cells.21 Spherocytes are less deformable than normal red cells.  So
they are trapped and engulfed by the spleenic macrophages. Spherocytes are
osmotically fragile. They have reduced surface area to volume ratio. Although most
common mode of inheritance is autosomal dominant, autosomal recessive
transmission occurs in some cases.
Normally, lipid bilayer of the red cell membrane is anchored to the underlying
skeleton by two major linkages. The first linkage involves interaction of ankyrin with
spectrin in skeleton and band 3 in the bilayer. The second attachment between
skeleton and bilayer is provided by glycophorin C and protein 4.1. Deficiency in any
of these interactions causes weakening of contact between lipid bilayer and skeleton.
As a result, areas of the lipid bilayer, which are not directly supported by the
underlying skeleton, are lost from the cells in the form of small lipid vesicles. This
causes decrease in surface area of red cell relative to volume with resultant spherocyte
formation. HS may result from deficiency of following skeletal proteins—spectrin 39
ankyrin 40, band 3, and protein 4.2.  The deficiency of Ankyrin is more common.41
Recently it has been shown that the outcome of splenectomy depends on the
cytokeleal membrane protein affected (whether predominantly spectrin/ankyrin, or
band 3).42
Hereditary Eliptocytosis (HE)
HE spans a group of disorders that show oval or elliptical-shaped red blood
cells on the peripheral blood film. It is caused by mutations in membrane skeletal
proteins that disrupt lateral interaction; contacts with the overlying lipid bilayer are
unaffected (unlike in hereditary spherocytosis). Mutations of alpha spectrin, beta
spectrin and protein 4.1 are responsible for 65%,30%, and 5% of cases of hereditary
elliptocytosis respectively.26
IMMUNE HEMOLYTIC ANEMIA
Haemolysis due to immune mechanism occurs when antibody and/or complement
bind to red cell membrane. In immunologically mediated haemolysis, destruction of
red cells usually occurs by type II (cytotoxic) hypersensitivity reaction. The antigen is
on the surface of the RBCs. The specific antibody in the circulation binds with the
antigen. This causes extravascular or intravascular red cell destruction.
Alloimmune hemolytic anemia requires previous senstisisation to allogenic
RBCs, which may be due to pregnancy, blood transfusion or transplantation. The
alloantibodies are non reactive towards autologous red cells. Drug-induced antibodies
are capable of recognising either intrinsic red cell antigens or the drugs bound to red
cells. It is difficult to differentiate between antibodies that react with intrinsic RBC
antigens and the autoantibodies.27 The bound antibody and the target antigen are
directly proportional to the degree of haemolysis. IgM antibodies are responsible for
lysis of red cells by the classical complement pathway and than the IgG antibodies.43-
45
By means of some trigger mechanism an autoantibody is synthesized which will bring
about an accelerated clearance of RBC lysis which will not be effectively
compensated by feedback mechanisms body resulting in haemolytic anemia.  T cell
regulation of  B cells will not be able to detect autoantiboby. The autoantibody
escapes in such a way that it makes subtle alteration in antigenic structure.45 Genetic
mutations, viral and bacterial infections, various inflammatory disorders, drugs,
lympho-proliferative disorders etc., leads to the production of autoantibodies.46-48.
Classification of AIHA is based on thermal characteristics of the antibody and
presence or absence of underlying disease. In AIHA, autoantibodies may be of IgG,
IgM, or IgA class. Generally, IgG and IgM antibodies are respectively of warm and
cold types; however in paroxysmal cold haemoglobinuria, IgG antibodies are of cold-
reactive type. Warm autoantibodies act avidly around 37°C and exhibit lower
reactivity at a redued temperature. Cold autoantibodies react more vigorously around
0-4°C and generally show less reactivity at physiologic temperature. Some patients
have both type of antibodies which is a very rare occurrence .27
MICROANGIOPATHIC HAEMOLYTIC ANAEMIA
This refers to haemolytic anaemia resulting from intravascular fragmentation
and lysis of red cells due to alteration in small blood vessels. Usually direct damage to
red cells occurs when they pass through the fibrin strands deposited in the
microcirculation. Common causes of microangiopathic haemolytic anaemia are
Thrombotic thrombocytopaenic purpura (TTP), Haemolytic uraemic syndrome
(HUS), Disseminated intravascular coagulation (DIC), malignant hypertension,
Eclampsia and Disseminated malignancies. Severity of anaemia is variable. The
characteristic feature on peripheral blood smear is fragmented red cells or
schistocytes. Schistocytes include small red cell fragments with 1 to 3 sharp spicules
as well as large helmet-shaped red cells from which fragments have been split off.
Evidence of intravascular haemolysis and consumptive coagulopathy is often present.
March haemoglobinuria
Intravascular haemolysis may result following physical exercise such as
marching or running on a hard surface for prolonged period (e.g. long-distance
runners). Traumatic destruction of red cells occurs within vessels of the feet. The
usual complaint is of passing reddish-brown urine following physical exertion.
Haemoglobinuria is transient in most cases. The degree of haemolysis is usually mild
and does not cause anaemia.
Cardiac haemolytic anaemia
Prosthetic cardiac valves may be associated with chronic intravascular
haemolysis. This may be related to turbulent blood flow resulting from leaking valve
and presence of artificial surface in bloodstream. Degree of anaemia depends upon
severity of mechanical damage to red cells.
Haemolytic anaemia due to direct action of physical, chemical, or infectious
agents
Physical agents
Acute intravascular haemolysis follows extensive burns and its degree depends
on body surface area involved. Haemolysis usually occurs within 1 to 2 days of burn
injury and is due to direct action of heat on red cells.
Chemical agents
Haemolysis can occur due to direct toxic action of some chemicals such as
lead, arsenic chloride (workers in galvanising or soldering industries), distilled water
(introduction of large quantity of distilled water in circulation may follow intravenous
injection or irrigation during surgery), and some insect venoms (spider).
Infectious agents
Malaria
Malaria is one of most common infectious cause for haemolytic anaemia. It is
caused by the following four species viz. Plasmodia: P. vivax, P. falciparum, P.
malariae, and P. ovale. Infected female Anopheles mosquitoes transmit the disease.
Recurrent high grade fever with chills and rigors, and splenomegaly are the
characteristic features. Icterus may be present. In P. vivax infection fever occurs on
alternate days, while in P.falciparum infection it occurs daily.
Problems with diagnosis of haemolytic anemias
Clinical features of haemolytic anaemia are varied and can be attributed to
anaemia, the compensatory response by the host, previous therapy and the primary
pathology causing it.  Patients may be asymptomatic for a long duration of time even
with a minimal but a chronic haemolytic process. Clinical manifestations may include
easy fatigability tachycardia, dyspnea, and angina. Chronic continued haemolytic
process leads to the development of bilirubin stones in the gall bladder and such
patients complain of abdominal pain. Bronzing of skin and diabetes are seen in
haemosiderosis; iron overload may occur in those who receive repeated transfusions
or those who have been underwent erroneous iron therapy. Dark urine may be due to
presence of haemoglobinuria as well as hemosiderinuria. Patients with thrombotic
thrombocytopenic purpura (TTP) may experience elevated body temperature,
neurologic signs, kidney failure, and low platelet count along with symptoms of
haemolysis. Leg ulcers may develop in patients with sickle cell anaemia and other
haemolytic disorders due to reduced red blood cell (RBC) deformability and
alterations of endothelial function.
On examination an individual with haemolytic anaemia may show signs of
anaemia and haemolytic process along with symptoms of primary pathology.
Generally patients present with generalised signs of anaemia like pallor of skin and
palpebral conjunctiva. But they may not specific for the underlying haemolytic
process.  Increased heart rate, increased respiratory rate, and fall in blood pressure are
due to anoxia and decreased blood pressure that can occur in severe anaemias but they
are also not specific for haemolytic anemias.  Jaundice may occur because of a slight
increase in UCB and the rise is not indicative of haemolytic disorders and can also be
seen in hepatic disease and obstruction of the biliary system. Bilirubin levels rarely
exceed 3 mg/dL in hemolysis, unless complicated by hepatic disease or gall bladder
stones. Enlarged spleen can be seen in hereditary spherocytosis and other haemolytic
disorders, but not in all. For instance, splenomegaly usually is absent in G6PD
deficiency. The occurrence of splenomegaly could suggest a hidden disorder such as
chronic lymphocytic leukemia (CLL), some lymphomas, or systemic lupus
erythematosis (SLE). Malar rash and polyarthritis could also suggest SLE. Enlarged
lymph nodes along with splenomegaly is consistent with CLL. An enlarged spleen
may not always be not evident on physical examination and imaging may be
necessary to define spleen size. Tenderness in right hypochondrium may indicate
cholelithiasis (pigment gallstones) or other gallbladder diseases. Tachycardia and
dyspnea may be evident when there is severe anaemia with an abrupt onset of
haemolysis such as in AIHA. Angina pectoris and symptoms of CCF may indicate a
cardiovascular pathology.
In all types of haemolytic anaemia evidence of heemolysis is appreciated by increased
LDH, increased levels of UCB, decreased haptoglobin levels, and increased
reticulocyte counts. But none of these indices are specific and with these parameters it
is difficult to distinguish among varied etiology of haemolytic anemias. In routine
clinical scenario the practical approach will be to differentiate between extravascular
haemolysis i.e destruction by monocyte-macrophage system (splenic and hepatic) and
the intravascular haemolysis   i.e  haemolysis occurring inside the blood vessels which
may be antibody mediated.
Generally, anaemia due to red cell intrinsic factors and immune mediated etiology are
extravascular. Microangiopathic haemolytic anaemia, infection associated and
chemical induced haemolytic anemias are intravascular. The following flow charts
provide a practical approach to investigate both intravascular and extravascular
haemolytic anemias.99
Variations in the Lactate Dehydrogenase levels and serum haptoglobin levels are the
most sensitive indicators of haemolysis. The UCB level is not always has a positive
correlation with haemolysis
Further laboratory evaluation may be directed by clinical history, clinical
examination, peripheral smear examination and other laboratory findings.
Ultrasonography is used to assess the spleen size, since the physical examination
occasionally cannot always detect splenomegaly. Chest X ray, electrocardiography
(ECG), and other studies are used to assess cardiopulmonary status.
RBC indices
Microcytic hypochromic anemia of iron deficiency will have a low MCV, and low
MCH along with high RDW.  This is because of low iron stores that can be confirmed
by iron studies that may be seen in chronic intravascular haemolysis as well. In a
haemolytic anaemia such as HS there will be ↑ MCV along with MCH and MCHC.
The increased demand for folate in chronic haemolysis may lead to megaloblastosis
and an increased MCV. RDW will reflect anisocytosis that has a varied significance in
diagnosing haemolytic anaemias.
Reticulocyte count
An elevated reticulocyte count represents good compensatory response by the
host to the anaemia irrespective of etiology whether haemolytic or non haemolytic. On
the other hand, decreased reticulocyte count does not rule out a haemolytic process or
it may be imperative that the host compensatory response is not adequate. Decreased
reticulocytic count may be seen in marrow suppression due variety of causes in spite
of an ongoing haemolytic process.
Thrombocytopenia is observed in a variety of haematological disorders. It is
seen in autoimmune disorders like SLE, haematological malignancies such as CLL,
and in a varied microangiopathic etiology. In Evans syndrome DAT test will be
positive  with low platelet counts.
Features on the PBF can help in the diagnosis of an underlying pathology
associated with haemolysis. For example, presence of spherocytes on a peripheral
smear may suggest a haemolytic disorder which may be correlated with other RBC
indices, the occurrence of schistocytes (fragmented red blood cells) suggests
thrombotic thrombocytopenic purpura, haemolytic uremic syndrome or  mechanical
damage or a haematological malignancy such as CLL are characterized  micro
spheroytes by an abundance of small lymphocytes and smudge cells  along with
polychromatophylic RBCs may mimic a haemolytic disease. Polychromasia indicates
RBC immaturity, which is an indicator of marrow response to an underlying
haemolytic pathology.
Serum LDH
Elevated levels of serum LDH is one of the most sensitive indicators of an
underlying haemolytic process. LDH elevation is sensitive for haemolysis, but not
specific since LDH can be derived from any cell undergoing damage such as
hepatocytes, tumor cells or from any other damaged viscera.  LDH isoenzymes 1 and
2 are specific for RBC destruction. These enzymes are seen elevated in myocardial
infarction as well.
Serum Haptoglobin
Decreased serum haptoglobin level is another sensitive indicator in a
haemolytic process. The level of serum haptoglobin has a positive correlation with
intravascular haemolysis than the extravascular one. The levels can be normal or
elevated even with significant haemolysis in patients having infections or other
reactive states.
Unconjugated bilirubin (UCB)
Unconjugated bilirubin though not a specific for hemolysis it is found elevated
in majority of haemolytic anemias.  The level of UCB rarely exceeds 3 mg/dL in
haemolysis and higher levels should raise the suspicion of compromised hepatic
function or cholelithiasis.
The direct Coombs test (DAT) is usually positive in autoimmune hemolytic
anemia (AIHA). Though a negative DAT does not rule out a AIHA. About 5-10% of
DAT negative coomb’s had been reported.49 The polybrene test, IRMA
(immunoradiometric assay) and  red blood cell–bound IgG are the other tests used to
evaluate DAT negative individuals. 50 Micro RNA analysis has been found to aid in
the diagnosis of AIHA in patients with CLL52 Either myoglobinuria or porphyria may
also result in dark urine and hence the urine should be tested for free hemoglobin.
Hemoglobinuria occurs when the amount of free hemoglobin released during
haemolysis is more than the available haptoglobin. Hemosiderin in the patients urine
may indicate severe or intravascular haemolysis. The source of urinary hemosiderin is
hemoglobinuria that occurs in severe and intravascular haemolysis and it is detected in
iron-stained urinary sediment in the renal epithelial cells that have been shed. When
hemoglobin in urine is reabsorbed by renal tubular cells, it is processed to
hemosiderin. Therefore, urinary hemosiderin reflects hemoglobinuria and suggests
severe or intravascular haemolysis.
Diagnostic difficulties with hereditary spherocytosis
The classic laboratory features of hereditary spherocytosis (HS) include the following
53,54
1. Mild to moderate anaemia
2. Reticulocytosis
3. Increased Mean corpuscular haemoglobin concentration
4. Spherocytes on the peripheral blood smear
5. Hyperbilirubinemia
6. Abnormal osmotic fragility test
In HS peripheral blood smear shows spherocytes which are uniform in size.
They lack the central pallor. In other haematological disorders like IHA,
microangiopathic hemolytic anemias the spherocytes show marked anisocytosis not
like HS.
MCHC is a sensitive indicator in a case of HS. MCHC > 35-36% is commonly
seen in HS.  Due to water loss within the cell MCHC will be found elevated. In HS
the MCV will be low owing to water loss as well as the red cell membrane.
The most sensitive test for HS is the incubated osmotic fragility test, which is
performed after incubating RBCs for 18-24 hours under sterile conditions at 37°C.
Osmotic fragility testing with RBCs that have not been incubated may demonstrate
haemolysis of HS cells in some patients but is not reliable. This is especially true of
newborns, as fetal red blood cells generally are resistant to osmotic haemolysis.
Further studies include to evaluate the specific membrane cytoskeletal abnormalities
are available in selected research centres. Several other tests are needed in patients
who have experienced an aplastic crisis. Testing for HSV, parvovirus B19, and EBV
may help to identify a viral cause for the aplastic crisis. In geriatric age group patients
must have an evaluation of their iron status, especially in setting of repeated blood
transfusions or if they have received prolonged oral iron supplementation for anaemia.
This evaluation includes measurement of serum iron levels and serum ferritin levels.
Patients with severe iron overload may present with hepatic dysfunction or
cardiovascular problems  or diabetes.
If the patient has suspected underlying haemolytic process along with right
hypochondriac pain, elevated body temperature, and leukocytosis, imaging studies
should be performed to rule out cholelithiasis due to a primary haemolytic disorder.
If there is suspicion of aplastic crisis, further evaluation of white blood cells and
thrombocytes should be done. A bone marrow aspiration study and biopsy will aid
further to make a correct diagnosis of  whether  aplasia or megaloblastosis.  Risk of
kernicterus is increased in newborn babies with ↑ bilirubin caused by HS.
In childrens splenectomy is done for HS after the age of 6 years. It is indicated in
children with moderate and severe HS. They will be presenting with severe anaemia
and growth retardation. Partial splenectomy is practiced nowadays which will
preserve the immune function and the marked reduction in the percentage of
haemolysis. 56,57
Diagnostic difficulties of Thalasaemias
A peripheral blood with target cells, and other features of anaemia  which may
be mild to severe. The MCV will be typically low and the red cell count will be low or
normal. RDW will be low in contrast to iron deficiency anaemia. Heinz bodies which
represent inclusions with in RBCs consisting of denatured haemoglobin may be seen
in PBF. 57 These findings along with other parameters like bilirubin, elevated
reticulocyte count, decreased osmotic fragility test, negative coomb’s test,
hemosiderinuria or hemoglobinuria and reticulocytosis will direct further confirmatory
tests in the line of thalassaemias.
Haemoglobin electrophoresis: This characteristically shows elevated HbF (10–
98%). HbA2 may be normal or increased. In homozygous β0 thalassaemia,HbA is
completely lacking, while in β0/β+ and β+/β+ thalassaemias, some amount of HbA is
present Haemoglobin electrophoresis with an  elevated HbA2 moiety  confirms a beta
thalasssaemia trait. In case of Sickle-cell β0 thalassaemia HbS is the predominant
haemoglobin (70–80%), HbA is absent, and HbA2 (3–5%), and HbF (10–20%) are
elevated. Diagnosis is confirmed by demonstrating that one parent has sickle-cell trait
and the other has β thalassaemia trait. A characteristic laboratory feature of β
thalassaemia minor is elevation of HbA2 (3.5–7.0%). HbF may be mildly increased.
In Haemoglobin Bart’s Hydrops Foetalis Syndrome the blood film shows
severe anisopoikilocytosis, microcytosis, and erythroblastosis. Haemoglobin level is 5
to 8 g/dl. Large amount of Hb Bart’s (approximately 80%) is present in cord blood.
Both HbA and HbF are absent since no α chains are synthesised. Globin chain
synthesis studies demonstrate complete absence of α chain synthesis (α/β ratio of 0).
Both the parents are obligatory carriers of α0 thalassaemia.
In Haemoglobin H Disease patients have anaemia (haemoglobin 7–10 g/dl),
icterus, and hepatosplenomegaly. Transfusions are usually not needed. Blood film
shows anisopoikilocytosis, hypochromia, microcytes, and target cells. When blood is
incubated with an oxidising dye such as brilliant cresyl blue, inclusion bodies are
formed due to precipitation of HbH. If spleen has been removed, preformed HbH
inclusions can be shown with methyl violet. Cord blood of the newborns shows 10 to
40% of Hb Bart’s that is slowly replaced by HbH during infancy. In adults, HbH
ranges between 5 and 40%. Both Hb Bart’s and HbH are fast-migrating haemoglobins
at alkaline pH (i.e. they move more rapidly than HbA). Globin chain synthesis studies
show α/β ratio of 0.2 to 0.4. Family study shows that one parent has α0 thalassaemia
trait (- -/αα), and the other has α+ thalassaemia trait (-α/αα), The increased Hb A2
level also is not seen in those with the rare delta-beta thalassemia trait. Increased Hb F
level is not specific to beta thalassemia trait.
SICKLE CELL ANEMIA
Patients with sickle cell disease will have moderate to severe anaemia, reduced
PCV,elevated total count with neutrophilia, low platelet count, decreased ESR and a
variable reticulocyte count. Peripheral blood film will show elongated hyper-
chromatic sickled cells with other features of anaemia. Howell-jolly bodies will be
seen in patient who underwent spleenectomy and hemoglobin solublity test will be
positive. But it will not differentiate between a sickle cell anaemia or a trait.
Hemoglobin electrophoresis is the investigation choice for HBS.  It
differentiation between homozygous and heterozygous variants.  The following table
describes the variants of sickle cell disease and genotypes, haemoglobin solubility
tests results and electrophoretic abnormality.
Table 2.sicle cell disease variants and the HB electrophoresis findindings
Sickle cell
disease
Genotype Clinical
manifestations
Solubility
test
Hb
electrophoresis
Sickle cell
anaemia
βS/βS Moderate to severe
anaemia; crises
+ HbS predominant;
no HbA; HbA2
normal
Sickle cell β0
thalassaemia
βS/β0 Moderate anaemia;
splenomegaly
persists
+ HbS predominant;
no HbA; HbA 2
increased
Sickle cell trait βS/βS No anaemia + HbA>HbS
Sickle cell β+
thalassaemia
βS/β+ Mild anaemia + HbS>HbA;
HbA2 increased
Typical abnormalities in patients with SCD are  anaemia with  Hgb level of 5-9
g/dL  ,decreased PCV in the range of  17-29 per cent, leucocytosi in the range of
12,000-20,000 cells/mm 3, with a predominance of neutrophils, thrombocytosis,
decreased erythrocyte sedimentation rate, increased reticulocyte count which may
vary depending on the extent of baseline haemolysis .
Peripheral blood smears demonstrate target cells, elongated cells, and
characteristic  sickle erythrocytes and occurrence of  RBCs with Howell-Jolly bodies
indicates that the patient is asplenic along with results positive hemoglobin solubility
testing  but  do not distinguish between sickle cell disease and sickle cell trait.
Hemoglobin electrophoresis helps to identify the individuals who are
homozygous for HbS from those who are heterozygous. It also confirms the diagnosis
of SCD by demonstrating a single band of HbS (in HbSS) or HbS with another mutant
hemoglobin in compound heterozygotes.
Neonatal Screening for Sickle-cell Anaemia
Screening can be carried out to identify those newborns who will later develop
sicklecell anaemia. The rationale behind this approach is that preventive measures can
be taken to avert serious complications and reduce morbidity and mortality in later
life. Screening of newborn can be carried out in communities with increased
frequency of sickle-cell gene. This approach is used in USA in African Americans.
In newborns, solubility test and sodium metabisulphite test cannot be used for
screening since concentration of HbS is very small (< 10%). Widely used test for this
purpose is citrate agar gel electrophoresis at acid pH. Haemolysate from cord blood
sample is used. Newborns who will develop sickle-cell anaemia show predominance
of HbF, some HbS and absent HbA; those with sickle-cell trait have HbF, HbS, and
HbA.
DIAGNOSIS OF G6PD DEFICIENCY
During haemolysis, general features of haemolytic anaemia are present.
Peripheral blood smear shows: polychromasia, fragmented red cells, spherocytes, bite
cells (red cells having bitten out margins due to plucking out of precipitated
haemoglobin by splenic macrophages), and half-ghost cells (one half of red cell
appears empty, while other half is filled with haemoglobin). Biochemical
investigations reveal unconjugated hyperbilirubinaemia, haemoglobinaemia,
haemoglobinuria , and decreased or absent haptoglobin.
Heinz Bodies
They can be detected after vital staining with methyl violet. They are usually
seen immediately following haemolysis. Heinz bodies are deep purple small
inclusions attached to red cell membrane. In addition to G6PD deficiency, they are
also seen in unstable haemoglobin disease. Qualitative or Screening tests like
Fluorescent spot test, Methaemoglobin reduction test,and Dye decolourisation tests
are used to screen this disease. During acute haemolytic episode, test for G6PD
deficiency may yield negative result due to reticulocytosis (since reticulocytes have
high G6PD content). In suspected cases, the test should be repeated about 6 weeks
after the haemolytic episode.
Quantitative assay of G6PD
This test is available only in reference laboratories. Haemolysate is incubated
with glucose-6-phosphate. The rate of reduction of NADP to NADPH depends upon
G6PD activity in the lysate. The rate of production of NADPH is measured in a
spectrophotometer at 340 nm and G6PD activity is derived. Genetic testing consists of
DNA-based genotyping and sequencing, which helps identify hundreds of mutations
associated with G6PD deficiency, including many region-specific common variants.
The molecular analysis may be useful for population screening, family studies,
females, and prenatal diagnosis.
MICROANGIOPATHIC HAEMOLYTIC ANAEMIA
This refers to haemolytic anaemia resulting from intravascular fragmentation
and lysis of red cells due to alteration in small blood vessels. Usually direct damage to
red cells occurs when they pass through the fibrin strands deposited in the
microcirculation.  Common causes of microangiopathic haemolytic anaemia are
Thrombotic thrombocytopaenic purpura, HUS DIC, Malignant hypertension,
disseminated malignancy Several infections and generalised vasculitis due to
immunologic diseases. The presentation depends on the underlying disease and the
anemia is of variable severity. The characteristic feature on peripheral blood smear is
occurrence of fragmented red cells or schistocytes. Schistocytes include small red cell
fragments with 1 to 3 sharp spicules as well as large helmet-shaped red cells from
which fragments have been split off. Evidence of intravascular haemolysis and
consumptive coagulopathy is often present.
Consistent findings in HUS include anemia and thrombocytopenia, with fragmented
red blood cells. WBC differential may reveal a left shift (ie, immature WBCs,
including bands, myelocytes, metamyelocytes). Individuals with Shiga toxin–
producing E coli hemolytic-uremic syndrome (STEC-HUS) may have very high WBC
levels, in the range of 50,000-60,000/µL. Antiglobin tests are negative, except with
S.pneumoniae –associated hemolytic-uremic syndrome. Reticulocyte count is
increased and levels of serum haptoglobin, are decreased. Prothrombin time (PT) and
activated partial thromboplastin time (aPTT) are normal with the levels of fibrin
degradation products being increased.
Testing for ADAMTS13 activity may help differentiate between atypical
hemolytic-uremic syndrome (aHUS) and thrombotic thrombocytopenic purpura
(TTP). ADAMTS13 activity less than 10% is consistent with a diagnosis of TTP.
Patients with decreased levels of ADAMTS13 activity should also be tested for the
presence of antibody to ADAMTS13. If plasma exchange is planned, specimens
should be obtained before starting plasma exchange, as the donor plasma may
confound the results. Rapid diagnosis is very helpful. Several laboratories offer 24-
hour turnaround service.
Utility of an isolated screening panel
Hemolysis is due a wide variety of etiology.  Some of the diseases are acute
like immune haemolytic anemias and some are chronic like the thalasaemias. Some
haemolytic diseases are associated with autoimmune diseases which will be diagnosed
with other manifestations of the primary disease. but when the compensatory
machanisms are acting in balance there will not be a clinical manifestation of disease.
So when the process of hemolysis is not compensated by bone marrow erythropoiesis.
It manifests as  any other case of anemia. Whenever a clinical suspicion of haemolytic
anaemia is made in our scenario patient will be .a n isolated panel is necessary for
1. Establishing the haemolytic process
2. compensatory state of the body
3. To establish etiology
4. Guiding for further investigations
5. To avoid unnecessary tests
Establishing the ongoing hemolytic process can be done by doing a CBC, serum
unconjugated bilurubin,and a reticulocyte count. Red cell kinetic and survival studies
are the definitive way of establishing haemolytic anemia.  The severity of anemia and
the reiculocyte count infers the severity of the disease and the ability of the body to
compensate for the loss. The peripheral smear combined with CBC guides in the
direction of further work up. By carful study of peripheral smear the following
inferences can be arrived. spherocytes ,elliptocytes, pyropoikilocytes can be made out
at the peripheral smear. Low MCV and with microcytic hypochromic anemia will
point towards thalasaemias. Normal MCV, target cells, poikilocytes like sickle cells,
and Hb crystals infer  hemoglobinopathies. Schistocyes are seen in microangiopathic
hemolysis. Fever with unusual red cell inclusions point towards infections like malaria
in Indian scenario. Agglutination is seen in immune haemolytic anemias which  can be
furthur evaluated by doing a cooomb’s test. Bite cell may be seen in membranopahies.
The extra vascular hemolysis is established by doing a simple test i.e hemosiderinuria.
It establishes a chronic haemolytic process. The intravaswcular hemolysis can be
established by hemoglobiuria.  Even though osmotic fragility test is not confirmatory
for a case of hereditary Spherocytosis it acts as a clue to further investigations like
family studies,or flowctometry.
Unlike the developed world where health related expenses are borne by insurance,in
our country  The patient has to spent for most of the tests. So unnecessary tests will
increase the cost of treatment and in some cases patients abandons treatment as it is
expensive. So a simple isolated screening panel will be of immense value in our
system.  The panel of tests are CBC, peripheral smear, reiculocyte count,
unconjugated bilurubin, coomb’s test,osmotic fragility test, benzidine test for
hemoglobinuria and  perls test  for  hemosiderinuria  whether serve the purpose wil be
analyed in this study.
Role of each tests
CBC (COMPLETE BLOOD COUNT)
Complete blood count is an important tool in diagnostic work up for anemias.
Complete blood count incorporates total WBC count, RBC count, differential count
(DC), haemoglobin concentration (Hb), mean corpuscular volume(MCV),packed cell
volume (PCV),mean corpuscular haemoglobin concentration (MCHC)  and red cell
distribution width(RDW). The indices pertaining to Red blood cells are called RBC
indices. By analysing values and histographs various types of anemias like microcytic
hypochromic anemias, megaloblastic anemias, various haemolytic anemias and
haematological malignancies, can be diagnosed. In the following paragagrahs the
parameters that vital to the diagnosis of hemolytic anemia will be analysed in brief.
TOTAL COUNT
The toal count signifies the total WBC count per cubic millimeter.  Whenever
there is inappropriate rise in total count a careful examination of peripheral smear to
be done yo rule out haematological malignancies or normoblastemia (nRBCs).
Nucleated RBCs (nRBCs) not seen usually in peripheral smear beyond neonatal
period. Their appearance beyond 5 th day of life in a normal infant signifies some
serious underlying etiology .premature birth, fetal hypoxia ,can increase the number.
But beyond the new born period the presence of nRBCs  is associated with malignant
neoplasms,disorders of bone marrow, and other serious disorders. normoblasts are less
deformable and and rarely enter circulation. whenever  the wbc count grossly elevated
as given by the automated hematology analysers ,the peripheral smear of the patient to
carefully reviewed for blasts or nRBCs.
Although studies show that even one nRBC in the peripheral blood of adults may
indicate a serious disease, clinicians and laboratory professionals do not agree on its
clinical significance, when they are not supported by other data. In primary health care
units, normoblastemia is rare and may signify a pathologic condition. In contrast,
normoblastemia is a common finding in an acute care hospital. As a result, NRBCs
may be perceived as ordinary cells of questionable clinical significance; in these
cases, the importance of normoblastemia is relative and depends on the type of
hospital and patient population. 100 The corrected WBC can be calculated from this
formula.
Corrected WBC count=100 x WBC÷100+nRBC
In advanced hematology analysers the corrected WBC count can be obtained.
Red cell indices
Red cell indices are derived from the values of red cell count, haemoglobin
(Hb) concentration, and packed cell volume (PCV). Red cell indices obtained by
manual methods are often inaccurate. Electronic haematology cell analysers more
reliably perform them.
The normal ranges of red cell indices in adults are as follows:
MCV = 80–100 fl
MCH = 27–32 pg
MCHC= 32–36 g/dl
1. Mean corpuscular volume (MCV): MCV represents the average volume of a
single red cell. It is expressed as femtolitres or fl (1 fl = 10-15 litres). MCV is
calculated manually as follows:
Packed cell volume in%
Mean cell volume (MCV) in femtolitres =   ____________________________   X 10
Red cell count in million per cmm
Anaemias are classified as normocytic, microcytic, and macrocytic on the basis
of MCV values. Since MCV measures average cell volume, it may be normal even
though there is marked variation in size of red cells (anisocytosis).  Normal range of
MCV is (80-100 fl). Low MCV is seen in thalassaemia minor,iron deficiency
anemia,sideroblastic anemia and anemia of chronic disease. High MCV is seen in Vit
B12 deficiency,bone marrow failure,and alcoholism.
2. Mean corpuscular haemoglobin (MCH):
This is the average amount of haemoglobin in each red cell. It is expressed in
picograms or pg (1 pg = 10-12 of a gram) and is derived manually from the following
formula:
Haemoglobin (g/dl) × 10
MCH (in picograms (pg))          =  _______________________________
Red cell count in million/cmm.
Low MCH is found in microcytic hypochromic anaemia, while high MCH in
macrocytic anaemia. Normal range of MCHC is 27-32 pg.
3. Mean corpuscular haemoglobin concentration (MCHC): This represents the
average concentration of haemoglobin in a given volume of packed red cells. It is
expressed in grams/dl and calculated as follows:
Hb (g/dl)
MCHC in g/dl 100 =     __________________________   X 100
PCV (%)
Normal range of MCHC is 32- 36 g/dl. Low MCHC haemoglobin concentration
(MCHC) in g/dl 100 occurs in microcytic hypochromic anaemia. An increase in
MCHC occurs in hereditary spherocytosis. Increased MCHC is is seen in HS,sickle
cell anemia,B12 & folate deficiencyHbC (homozygous) and low MCHC is seen in
Iron deficiency anaemia and haemorrhagic conditions.
Red cell distribution width (RDW): Automated analysers produce a quantitative
measurement of the variation in cell volume, an equivalent of the microscopic
assessment of the degree of anisocytosis. This parameter has been named the ‘red cell
distribution width’.
The RDW is derived from pulse height analysis and can be expressed either as the
standard deviation (SD) in fl or as the coefficient of variation (CV) (%) of the
measurements of the red cell volume. The RDW SD is measured by calculating
the width in fl at the 20% height level of the red cell size distribution histogram and
the RDW CV is calculated mathematically as the coefficient of variation,
i.e. RDW (CV)= 1SD/MCV X 100%.
Most instruments express the RDW as the SD, but Sysmex instruments and the
Beckman Coulter instrument express it as both SD and CV.
The normal reference range is in the order of 12.8 +/- 1.2% as CV and FOR  SD
42.5 +/-_ 3.5 fl as SD.
However, widely different ranges have been reported; therefore it is important for
laboratories to determine their own reference ranges. The RDW expressed
as the CV has been found of some value in distinguishing between iron deficiency
(RDW usually increased) and thalassaemia trait (RDW usually normal) and between
megaloblastic anaemia (RDW often increased) and other causes of macrocytosis
(RDW more often normal).
The following flow chart can be of useful interpretation of various haemolytic
anemias.
Figure – 3. Correlation of RDW with other red cell indices
Peripheral smear
Morphology of various cell lineages can be analyed with the help of peripheral
smear. PBF is a vital tool to a hematopathologist. Progression of a haematological
disorder and its response to treatment can be assessed by a peripheral smear.
Literature reveals more than seventy percent of clinical decisions and diagnoses are
supported by a good clinical haematologist. 59..The PBF exposes the morphology of
peripheral blood cells, which ensures its place in the morphologic diagnosis of various
primary and secondary blood and blood related diseases such as haemolytic anemias
and haematological malignancies.
Romanosky stains are  commonly employed in staining of PBF  which gives  a
differential staining in a way that  it stains the acidic and basic components in a
different colours.60 Leishman stain is most commonly used stain in our laboratory
which is composed of eosin (acidic component) and polychrome methylene blue
(basic component). Some laboratories use MGG (May-Grunwald Giemsa) or Wright-
Giemsa stain. 61
Interpreting a peripheral blood film is done by preferably by a
hematopathologist especially for slides that show pathology.62,63 The method of
viewing a slide is to start from the tail of the smear and concentrate on the junction of
the body and the tail where the cells start just overlapping.  The head portion is
significant while examining the slide for hemoparasites.  The feathered portion should
be examined when a haematological malignancy is suspected and platelet clumps are
mostly concentrated near the tail of the smear. White reporting a smear one should
take into account, the morphology, inclusions of all cell lineage.  However,
fragmented cells and artifacts also should be taken into account.
The shape of normal RBC is biconcave disc-shaped with 7–8 µm. Each cell has
central palor occupying about 1/3rd of total volume, surrounded by pink colour
imparted by Romanowsky dye.  The eosin imparts the pink colour which is taken up
by the cytoplasm of red blood cells which is acidic 64. Red cells show wide variation
in size which is designated as anisocytosis and it can be either microcytic macrocytic,
macro-ovalocytic or normocytic.  A mean-corpuscular volume of < 74fl suggests
microcytosis while if it is more than   96% fl suggests macrocytosis.  Ovalo-cytosis is
seen in megaloblastic anaemias (B6 or B12 deficiency), drug-induced or
mielodysplastic syndrome. In liver disease and alcoholism there will be plenty of
round macrocytes in PBF.
Table no.3 showing various peripheral smear findings and their differential
diagnosis
Red Cell Shapes Differential Diagnosis
Irreversibly sickled red cells (Drepanocytes) Sickle cell syndromes  (SS, SC, Sβthalassemia)
Target cells (codocytes, Mexican hat cells)
(Fig 7)
Sickle cell disease, haemoglobin C trait,
haemoglobin CC disease, thalassemia, iron
deficienty, Liver disease (Cholestasis) asplenia
Fragmented red cells (schistocytes, helmet
cells, keratocytes)
Thrombotic micro-agniopathic haemolytic
anaemias such as Disseminated intravascular
coagulopathy, (DIC), thrombotic
thrombocytopenic purpura, haemolytic uraemic
syndrome
Burr cells (echinocytes, crenated red cells) In-vitro artefact following prolonged storage or
slow drying of the smear due to high humidity,
uramia, Malnutrition
Spur cells (acanthocytes) Liver disease, Renal failure,
Abetalipoproteinaemia, Spur cell anaemia,
pyruvate kinase deficiency
Tear drop cells (dacrocytes) Myelofibrosis, Myelophthsia (marrow
infiltrations), Extramedullary haemopoiesis,
Hereditary  elliptocytosis, Hereditary
pyropoikilocytosis, Severe iron deficiency,
Megaloblastic anaemia, Thalassemias,
Myelodysplastic syndrome
Bite cells (degmacytes) G6PD deficiency, Oxidative stress, unstable
haemoglobins, congenital heniz body anaemia
Pencil cells Iron deficiency
Stomatocytes Artifact (due to slow drying in humid
environment), Liver disease, alcoholism,
Obstructive lung disease
Elliptocytes(fig7) Hereditary Elliptocytosis (>25%)
Basket cells (half ghost cells Blister cells)
spherocytes
Oxidant damage, G6PD deficiency, Unstable
haemoglobins Hereditary spherocytosis, ABO
incompatibility, Autoimmune haemolytic
anamia (warm antibody type) Severe burns
Red cell inclusions are due to defective maturation of RBC.  oxidant injury to
the cells or infections. In post-splenectomy individuals and in anatomical and
functional asplenism, Howell jolly bodies are seen which are remnants of DNA.
Some of the hemoglobinopathies, some of the poisoning like led are arsenic and in
some severe infection, Basophilic stipplings which are denatured RNA remnants
found in the PBF. Reticulocytes exhibits polychromasia on Rowmanosky stained
slides.  They are released in premature from the marrow sinusoids and taken about 1 –
2 days for maturation.  Increased nucleated RBCs in PBF indicates severe stress on
marrow causing premature release of RBCs.  When, premature RBCs along with
precursors of WBC lineage like band forms is termed as leucoerythroblastic picture.
A haemoglobin content is directly proportional to the colour of the red cells.
Hyperchromia signifies increased haemoglobin content, whereas hypochromia
indicates decreased haemoglobin content.  Hyperchromatic RBCs lacks the palar
central area which can be larger (Polychromotophilic RBCs) or small cells
(microspherocytes)  Pyknocytes are irregularly contracted cells which have and
abnormal cells with hyperchromia.  Uniform sized spherocytes are seen in hereditary
spherocytosis (HS) where as microspherocytes are seen in IHA (immune haemolytic
anaemia) and burns.  Crenated red cells are due to storage for long hours.  Leptocytes
which ae hypochromatic large cells with the thin rim are seen in liver diseases.
The WBC (white blood cell) morphology and much of WBC disorders can be
diagnosed with peripheral smear. The same applies platelets as well.  Wide variations
in WBC morphology and count can be seen in a variety of haemolytic disorders.
Whenever there is WBC more than 5 per hpf, it is designated as leucocytosis, whereas
WBC < 2 signifies lucopenia.  The accuracy will be better, if more number of fields
are examined.  So, cell count estimation of leucocytes will be better in a low-power.
Especially, when conditions like pancytopenia bone-marrow aplasia are suspected.
PBF is of diagnostic significance in certain conditions like sickle cell disease,
hereditary eliptocytosis or spherocytosis.  So, an accurate diagnosis warrants a sound
clinical knowledge of different cytomorphological abnormalities of a disease with
good laboratory experience.
RETICULOCYTE COUNT
Reticulocytes are anucleated cells, more rounded in shape and 20 per cent
greater, in volume, than the erythrocytes. They produce polychromatic slides, when
stained with panoptic dyes (Romanowski), as the result of mature red blood cells with
hemoglobin, synthesized during maturation, and also reticulocytes with ribonucleic
acid residues. Microscopic studies reveals characteristic aspect of reticulum, when the
residues are stained with new methylene blue or brilliant cresyl blue dyes.65
Based on the granules within the reticulocytes can be graded in to 4 groups.
Group 1 is the most immature group which will have more RNA contents.  Group-2 &
3 are intermediate groups which will have RNA content in between group 1 and 4.
Group 1 will have lesser RNA content which will appear as dots within the RBCs.
So, reticulocyte count is a common to for assessing marrow activity with respect to
ongoing haemolytic process.  It is also useful after bone-marrow transplant and post-
chemotherapy assessment of marrow activity.  The reticulocyte counting by manual
method was first explained during 1930, and still practised world-wide.  Compared to
costlier automated method, the manual one is cheaper.  However, manual counting
presents some factors that cause great variation.
Peebles et al68 reported inter observer variation coefficients between 25 per
cent and 50 per cent, considered higher than the expected one. For more precise
results, manual counting must follow standardized criteria of execution and
identification. As suggested by the H-44 technique norms of the National Committee
of Clinical Laboratory Standards (NCCLS) and of the International Committee for
Standardization in Hematology (ICSH), some criteria must be observed for a good
performance of reticulocyte manual counting with special attention to the
differentiation among reticulocyte granules, Pappenheimer, Heinz, and Howell-Jolly
bodies, or remaining dyes and  taking special care in the preparation of the
reticulocyte slides avoiding  overlapping of  cells and also  accounting  the number of
evaluated cells. 69
In rural regions of India, manual technique is widely practised.  By staining
with new methylene blue or brilliant cresyl blue and interpreted by a trained
microscopist or hematopathologist.  It is simple but it has its own flaws, there is a 25 –
50 percent inter-observer variation .70,71 There are many factors that affects the results
of  the manual method like experience of the hematopathologist usage of ocular inset
and the quality of the smear and the total number of fields counted. 72 However, the
accuracy and precision can be obtained in automated machines.76
Non-fluorescent (Oxazine 750, new methylene blue), and fluorescent (thiazone
orange, auramin O, cyanene) dyes are used by the principle of flowcytometry to
estimate the reticulocytes. 73Introducing maturation indices and volume
measurements, automated reticulocyte counting adds a vital method for analysis. 74-76
The proper evaluation of reticulocyte count is hampered by the presence of cells like
schistocytes nRBCs, cell debris, hemoparasites and giant platelets.
The peripheral blood sample is stained with supravital stain (brilliant cresyl
blue or New Methylene blue).  These are basic dyes that have the ability to react with
ribosome and nucleic acids of reticulocytes while it still alive. The neuclic acid dye
reaction form a blue precipitate of granules or filaments.
The normal range of values for reticulocytes in the blood depends on the
clinical condition and the laboratory standards, but the value of 0.5 per cent to 1.5 per
cent is considered normal. However, in case of anemia the reticulocyte count should
high.  However, in many times the proportionate elevation cannot be established.  So,
the reticulocyte production index is an important parameter calculated from retic
count and the RBC count which will be used to assess the appropriateness of the retic
count with regarding to the given clinical scenario.
The reticulocyte count is also useful in the management of patient therapy. It
can be used to follow idiopathic myelofibrosis, 79 evaluate a patient’s responsiveness
to folate, iron, or B 12 supplementation, follow the progress of bone marrow
transplant,80 and assess the impact of chemotherapy and radiation on
hematopoieticfunction.81
Bilirubin
Bilirubin is an endogenous compound and   is yellow in colour. that can be
toxic when in excess .Bilirubin has a yellow colour with, for the unconjugated
molecule a typical spectrographical peak at 450 nm 82.  Bilirubin plays a protective
role when is mildly elevated. It protects  against neoplasms and CVS diseases.
Bilirubin is produced by the breakdown RBC at the reticuloendothelial system. It is
derived from the haem moiety of haemoglobin.the daily production of about 200-300
mg in an adult 83per 24 hours. More bilurubin is produced in neonates compared to
adults.conjugation of bilirubin occurs in the hepatic microsomes. The conjugated
bilurubin excreted in bile which is mediated by a transporter called MRP2 which
belong to the ATP .85 the bilurubin is transported to intestine where major part of it
undergoes enzymatic breakdown. A minor portion of it gets deconjugated and
reabsorbed and will remain as UCB.  Disorders of Bilurubin metabolism can be
categorised under unconjugated bilirubinemia,conjugated bilirubinemia,and  mixed
type.it is based on the DB/TB ratio.if it  is unconjugated bilirubinemia the value willbe
20-30%,>70% signifies conjugated bilirubinemia and the values will be  between
these two in mixed type. 86In most of the laboratories esmation of TB and CB will be
done and UCB is calculated from the above values. In haemolysis the bilurubin
content will be abnormally high.87whenever there is haemolysis the bone marrow will
compensate with production of more immature cells pushed into circulation to
compensate the loss. These immature cells i.e normoblasts which have a short half life
compared to the matured ones .so they undergo earlier lysis.thus increasing the UCB
percentage.
Haemolysis is one of the most common causes of unconjugated
hyperbilirubinaemia. 88 During activated synthesis of RBC in the bone marrow
compartment due to any etiology. Anemia may not be evident but unconjugated
bilirubinemiacan be evident due to accelerated destruction of RBC. Elevated bilirubin
levels are seen in haemolytic diseases like thalassaemia, sickle cell anemia,and
hereditary spherocytosis . it can also be markedly elevated in diseases like Gilbert
syndrome.89,90
Principle
The most widely followed and simple method is Diazo method of Pearman
&lee(end point).the principle is that bilurubin reacts with diazotised sulphanilic acid in
acidic medium to form pink coloured azobilurubin with absorbance that is directly
proportional to bilurubin concentration .direct bilurubin, being water soluble directly
reacts in acidic medium. However indirect or unconjugated bilurubin is solubulised
using a surfactant and then it reacts similar to direct bilurubin.
COOMB’S TEST
Anti human globulin test (AHG) comprising of both Direct Coombs’ Test (DAT) and
Indirect Coombs’ Test (IAT) can be used to detect RBC sensitized with Ig G auto and
alloantibodies, complement occurring in vivo and vitro. Anti human globulin test is
the mainstay of any immune hematological work up. Interpretation of AHG is a
significant step and which should be mandatory for the better management of patients.
Coombs’ test also known as Anti Human Globulin test (AHG) was described in
1945, by Coombs and associates for detection of weak and nonagglutinating Rh
antibodies in serum. Direct antiglobulin test (DAT) was described by Coombs and
coauthors in 1946 describing use of AHG to detect in vivo sensitization of RBC of
babies suffering from hemolytic disease of new born (HDN).91 detect RBC sensitized
with Ig G alloantibodies.
The Antiglobulin test can be used to Ig G autoantibodies and complement
components occurring invivo or in vitro. Indirect Antiglobulin Test (IAT) refers to the
use of AHG in detecting in vitro sensitization of RBC as two-stage technique. The
present study deal with the evaluation of DAT and IAT in all the
immunohematological cases keeping in view to the past and present medical history
and presentations.
DAT, 1-2 drops of EDTA anticoagulated patients’ red cells were washed three times
with isotonic saline in test tubes. After decanting the supernatant completely following
the third wash, to the dry botton Polyspecific AHG was added and incubated in the
room temperature for 5 minute. The tubes were centrifuged at 1000rpm for 1 minute.
Immediately after gentle re-suspension of the agglutination, macroscopic examination
was done using lighted agglutination viewer. When the result was negative, we
examined for the agglutination under microscope. To negative result interpreted
microscopically, one drop of Ig G-coated Coombs Control Cell was added to the tube
and centrifuged lightly for 1 minute at 1,000 rpm. It was immediately re-suspended
gently and examined macroscopically for agglutination. A positive reaction at this
state confirmed a negative test. If the result was negative after addition of the Ig G
coated Coombs Control Cells, the test was reported to be invalid and was repeated.
For IAT,1 to 2 drops of patient’s serum 1 drop of 5% saline-suspended reagent group
O cells is added in the test tubes and mixed. The test tubes were then centrifuged at
1000 rpm for 1 minute and were observed for hemolysis and agglutination. The tubes
were incubated at 37 C for 30 to 60 minutes followed centrifugation and observation
was done for hemolysis and agglutination. Again, red cells were washed for three
times with saline; completely decanting the final wash.AHG was added to the dry red
cell button and was mixed well. The test tubes were centrifuged and were observed for
agglutination. Results were graded and were recorded. Validity of the negative results
was confirmed by addition of IgG-coated red cells.
Antiglobulin test detects red cell antibodies which are bound and do not produce
direct agglutination.AHG reacts with human antibodies  and complement bound to red
cells and also unbound to cells, free in serum.AHG sera can be used for performing
DAT and IAT.DAT  demonstrate in-vivo sensitization of red cells and is performed on
the patients’ washed red cells to which AHG is to be added.IAT demonstrates in-vitro
reactions between red cells and antibodies which can be performed on serum of
patients from which red cells are washed to remove unbound globulins.2DAT is the
investigation of choice in hemolytic disease of the fetus and newborn (HDFN),
transfusion reactions, autoimmune hemolytic anemia (AIHA), and drug-induced
immune hemolysis. The predictive value of positive DAT is 83% in a patient with
hemolytic anemia, and only 1.4% in a patient without hemolytic anemia.92
IAT is used for antibody detection, antibody identification, cross matching and
blood group phenotyping. DAT is performed by testing freshly washed red cells
directly with Antiglobulin reagents containing anti-IgG and anti-C3d.False negative or
weaker result can be obtained if the  washed red cells are allowed to sit before testing
with anti-IgG or delay in the reading. False positive results can arise in degradation of
specimens causing non-specific binding of DAT reagents. Causes of false positivity in
Antiglobulin test include over-centrifugation,under agitation, prolonged delay in
testing, clotted specimen, reagent issues and spontaneous agglutination.93,94 Causes of
false negative results include neutralization of AHG reagent by failure to wash
inadequately, interruption in testing, improper reagent storage,over-
centrifugation.95Positive DATs are reported in 1:1000 upto 1:14,000 blood donors and
1% to 15% of hospital Patients.96
OSMOTIC FRAGILITY TEST
The confirmatory test for HS is osmotic fragility (OF) test which determines
susceptibility of red cells to haemolysis during osmotic stress conditions. Haemolysis
can be measured when the cells are suspended in decreasing concentrations of
hypotonic saline solutions where, the water enters in to the red cells. Due to their
biconcave shape, normal red cells can withstand hypotonicity by increasing their
volume to certain limit and after that they cannot swell leading to cell burst, by
discharging their haemoglobin into the supernatant. Spherocytes have a decreased
surface to volume ratio and therefore, they are able to withstand less swelling than
normal and are osmotically fragile, i.e. haemolysis occurs in more concentrated
solution than normal cells. Osmotic fragility test are performed by Highest
concentration of saline at which haemolysis starts (normal 0.50 g/dl NaCl) and the
highest concentration of saline at which it is complete (normal 0.30 g/dl of NaCl) or
by Concentration of saline showing 50 per cent lysis (Median corpuscular fragility) or
by normal value is 0.40 to 0.45 g/dl NaCl. Increased value is proportional fragility. A
graph may be plotted with amount of haemolysis on vertical axis and saline
concentrations on horizontal axis. Normal osmotic fragility curve is sigmoid shaped.
Shift of the curve to the right indicates increased osmotic fragility.
Osmotic Fragility Test after Incubation
Osmotic Fragility Test is performed by incubating sterile blood at 37°C for 24
hours and in hypotonic saline solutions. During incubation, metabolic deprivation of
spherocytes occurs mainly due to decreased concentration of glucose, with resultant
membrane destabilisation, loss of membrane, and enhancement of spherical shape.
Due to the failure of membrane pump with accumulation of sodium and water also
counterpart this lysis. The sensitivity of the test is thus increased. Incubated OF test
may, however, be normal in 10-20 per cent of patients with HS .
The osmotic fragility is increased in any disorder associated with spherocytosis
and is thus not specific for HS. Normal OF test result does not rule out HS as it may
be normal in mildly affected patients. Diagnosis of hereditary spherocytosis is usually
easily made on the basis of mild to moderate anaemia with spherocytosis,
splenomegaly, jaundice, increased osmotic fragility, and evidence of hereditary
spherocytosis in the first-degree relative. Sometimes anaemia is mild or absent and the
patient may first present with isolated splenomegaly, gallstones, or “aplastic crisis”.
Clinical evaluation and examination of blood film for spherocytes are necessary for
correct diagnosis.
A spherocyte is a small sized red cell, does not have central pallor and appears
densely haemoglobinised (hyperchromic) (fig. 9). Spherocytes, in not only unique to
HS and are also found in other disorders such as immune haemolytic anaemias, ABO
haemolytic disease of the newborn, haemolytic transfusion reactions, and burns.
Increased osmotic fragility is due to spherocytosis, which may result from a variety of
causes (HS, immune haemolysis, burns, etc.). Therefore, OF test is not specific for
diagnosis of HS and has certain limitations. OF test is normal in patients with mild HS
having very few spherocytes in their blood. Incubation at 370 C increasesthe
sensitivity of OFT.   This test is time-consuming and a tedious one and if spherocytes
are present on blood smear, adds little to diagnosis. Decreased osmotic fragility
(increased resistance to lysis in hypotonic solutions) is seen in iron deficiency
anaemia, thalassaemia, sickle-cell disease, and liver disease and hence result negative
for patients with above said disorders. OF test cannot distinguish between causes of
spherocytosis.
Hemoglobinuria
Red blood cells contains haemoglobin, iron rich molecule helps transport O2
and CO2 through the body. RBC have life span approximately of 120 days and they
undergo lysis. This occurs in the spleen, bone marrow, and liver. If there is
intravascular hemolysis RBCs break down with in the blood vessels, the fragmented
cells move freely in the bloodstream. Higher concentration of Hb begins to appears in
the urine and such condition is termed as haemoglobinuria leading to intravascular
hemolysis.
Diagnostic symptoms viz., Acute haemolytic conditions like incompatible
blood transfusion Hemolytic anemia due to drugs and chemicals, Favism, Paroxysmal
cold hemoglobunuria, March (exertional) hemoglobunuria, Haemolytic anemia
associated with eclampsia, Haemolytic uraemic syndrome, Haemolytic anemia due to
burns ,Snake and spider bites. Chronic causes are PNH, Cardiac hemolytic anemia and
Cold haemagglutination disease are some of the auses of hemoglobinuria  include
Occurrences of Hemoglobinuria may be evidently clear from random urine
sampling or it can be detected in urine samples obtained in successive intervals.
Hemoglobinuria may vary dramatically with in a same day or even hour to hour.
Haemoglobinuria is excretion of free haemoglobin in urine, develops when plasma
haptoglobin cannot bind any more haemoglobin.
The reabsorbed haemoglobin stored as ferritin or haemosiderin in proximal
renal tubular epithelial cells. And as the result their shedding causes, haemosiderinuria
in urine. The confirmation test for Haemoglobinuria is benzidine or orthotoluidine test
on urine sample and urinary sediment can be identified by Prussian blue staining.
This is actually an oxidation reaction, where the peroxidase activity of
hemoglobin in urine decomposes hydrogen peroxide and liberates oxygen, which
oxidizes benzidine to form a green- blue colored complex and this forms the
confirmative test for hemoglobinuria, myoglobinuria and hematuria. This test should
be avoided during menstruation cycle because false positive results will be seen in
women during menstruation, due to contamination of urine with menstrual blood.
Hematuria can be differentiated from hemoglobunuria by microscopical examination
alone. Even positive results for occult blood tests, RBC cannot be found in such
hemoglobunuria conditions.
Hemosiderinuria
Hemosiderinuria (syn. haemosiderinuria), defined as "brown urine", occurs in
addition with chronic intravascular hemolysis. Hemosiderin is nothing but a form of
iron that results from the denaturation of ferritin. These insoluble granules are
identified by staining with Prussian blue color which grows in size that can be
observed microscopically in the urine sediment. Hemosiderin granules are found in
the urine sediment 2 to 3 days after a severe hemolytic episode (e.g., transfusion
reaction, paroxysmal nocturnal hemoglobinuria). the plasma Hb level is  between 50
to 200 mg/dL following hemolysis. if the haptoglobin  is incapable of binding Hb, and
immediately passes through the renal glomerular system. Part of the Hb is absorbed by
the proximal tubules where the hemoglobin is converted to hemosiderin. As a result
these tubular cells shed into the urine, as hemosiderinuria. The unabsorbed forms in
tubular cells end into hemoglobinuria. Hemosiderin is seen as yellow-brown granules
that are free or in epithelial cells and occasionally in casts in acidic or neutral urine.
Rous Method
Prussian blue stained Hemosiderin can be identified as free floating or in
epithelial which was first studied by Rous in 1918 to identify urinary siderosis, where
the granules appear as characteristic blue.97Hence this reaction gets its name, the
Prussian blue reaction, which is also called as the Rous test. For this test concentrated
urine sediment is used for examinination and for the presence of coarse yellow-brown
hemosiderin granules, free floating or within casts or tubular epithelial cells is positive
identification. The urine sediment is suspended in a freshly prepared solution of
potassium ferricyanide–HCl and is allowed to stand at room temperature for 10
minutes and centrifuged and the sediment is used reexamined for the presence of
coarse blue granules. The hemosiderin iron causes the granules to stain Prussian blue.
Sometimes this reaction may be delayed so for further confirmation, the negative
sediments are examined after 30 minutes.98
A smear is prepared with sendiments of centrifuged 10 ml of early morning
sample and which is fixed by methanol. Later stained using mixure of 2 per cent
potassium ferrocyanide and 1 per cent HCl in equal volumes and kept undisturbed for
10-15 minutes.  Further a counter stained, eosin dark blue granules were used and
observed under microscope as in bone morrow indicates a positive test.
Materials and methods
This chapter deals with the methodology and procedures for the prospective study on
types haemolytic anaemia.  The present study was carried out at the Department of
Pathology at Tirunelveli Medical College and Hospital during September 2013 to
September 2015. The study population are irrespective of their age and sex the
patients diagnosed clinically as haemolytic anaemia and the patients referred to
clinical pathology lab with anaemia and peripheral smear study showing features of
haemolysis.
Inclusion criteria
This study comprises all catogories of patients irrespective of the age and sex
who possess the evidence of haemolysis and haemolysis of both intravascular and
extravascular  etiology.
Exclusion criteria
There are some lacuna that has to be omitted is this due course of research
which comprises, Anaemia caused by nutritional cause, hematopoietic malignancy
and aplasias. Evidence of clinical disease but without laboratory evidence is not
included in the study. The patients who possess the necessitate symptoms were
examined and their absolute details were acquired from them in person and were
documented and filed. Complete clinical history of the patients presenting with
symptoms viz., pallor, dyspnoea, hematuria and fatigue and their order of presentation,
onset and duration of symptoms, family history, history of co morbid conditions like
diabetes, hypertension, autoimmune diseases and prosthetic valve were obtained in
detail and the acquired information were addition support for this research.
A complete clinical examination was performed as per the diagnostic procedure.
Patient is specifically examined for spleenomegaly and jaundice.  The blood sample
and urine samples of selected patients were collected and labelled for further analysis
and investigated.
Collection of blood:
From each patient undergoing evaluation of hemolysis 6 ml of venous blood
were collected by venipuncture at the ante cubital fossa under aseptic precautions and
were labelled for further diagnostic exploration. Nearly 6 ml of blood is separated into
three different tubes with 2ml each.  First one in the   EDTA tube is used for complete
blood count, peripheral smear and direct coomb’s test. The second tube is a
heparinised one which is used solely for osmotic fragility test and the last blood
sample of 2ml is a clotted sample, collected into a plain tube  which is used for
indirect coomb’s test and for serum bilurubin estimation.
Collection of urine:
Tem ml of fresh early morning sample of mid stream urine is collected in a
sterile plastic container. The urine sample is centrifuged and the sediment is made in
to smears and it is tested for hemosiderin. From that sample, 1ml sample is taken to
test hemoglobinuria. After collection of samples the following panel of tests are
performed to type the haemolytic anemia.
1. Complete blood count
2. Peripheral blood smear
3. Bilurubin estimation (direct and indirect)
4. Reticulocyte count.
5. Osmotic fragility test
6. Hemoglobinuria
7. Hemosiderinuria
8. Coomb’s test (direct &indirect)
CBC
Complete blood counts for all the samples was done using SYSMEX 3 part
differential analyzer and the RBC indices was noted along with total WBC count,
differential count, platelet count and hematocrit.
Peripheral blood smear
A clean oil free glass slide and a spreader with smooth edge were taken to
perform the peripheral blood smear preparation. A drop of fresh blood or  EDTA
blood is placed at one end of glass slide one cm from the edge and gently it was
spread by the spreader at 450 to the surface of the slide, and it is moved back and to
make contact with the blood. Blood drop were allowed to spread along the line of
contact. Smear is made with a swift movement. The film should end at least one cm
away from the edge. The slide were undisturbed and allowed to dry at room
temperature.
The smear is placed on two parallel glass rods which are fixed across a sink.
The Leishman’s stain (1.5 grams of leishman’s powder is dissolved in 100 ml of
acetone free methyl alcohol and allowed to ripe for 4-6 weeks) is poured onto the slide
until the film is fully covered, and allowed to sit for 1-2 minutes. More stain was
added to counteract evaporation. It should never be allowed to dry. Later it is diluted
with equal volume of buffered water. The diluted stain is allowed to act for 3-5
minutes, and then it is flooded with excess buffer water or with tap water. Then the
under surface of the slide is wiped with a piece of filter paper. The slide is allowed to
air dry.
Bilurubin estimation
Bilurubin is estimated by diazo method. the reagent used is Liquixx bilirubin  reagent.
The test was run using a blank for every sample.500 micro mi of reagent is mixed
with 25 micro ml of test serum and incubated at room temperature for 5 minutes.it is
compared with a standard .read the absorbance at 546/630 nm against reagent blank.
Total bilurubin and conjugated bilurubin is calculated by the following formulas
respectively.
Bilurubin (mg/dl) = absorbance of test x concentration of standard divided by
Absorbance of standard
Direct bilurubin (mg/dl)=absorbance of the test xconcentratin of standard (mg/dl)
divided by absorbance of the standard
Reticulocyte count
Reticulocytes are immature RBCs. They contain large amount of RNA,
mitochondria and ribosome which react with some basic dyes like new methylene blue
or brilliant cresyl blue to form purple precipitate of granules or filaments(fig 8). They
are stained while they are alive. Therefore it is called supravital staining.
Nearly 2-3 drops of EDTA anticoagulated blood is taken in a small test tube
and 2-3 drops brilliant cresyl bue stain were added to it. These are thoroughly mixed
and incubate at 370 for 15-20 minutes. A drop of incubated blood- stain mixture is
placed on a slide and spread as a blood film and allowed for air drying. It is examined
under a microscope and one thousand RBCs are counted, and the number of
reticulocytes seen during the count is reported as a percentage of total number of
RBC.
Osmotic fragility test
The red blood cell has a semi permeable membrane, through which many small
substances, including water and electrolytes, can pass relatively freely back and forth.
The cell has to work at keeping the normal internal electrolytic concentration (the
level of potassium is much higher inside the cell than outside, while the intracellular
sodium is lower than in the plasma) and to maintain its normal shape. If the cell is
placed in saline solutions which are hypotonic, water from the solution will cross the
semi permeable membrane into the cell where the concentration of salts are more,
which will lead to the swelling of the cell (it  will become more spherocytic) and
ultimately it will lead to cell rupture. On the other hand, if the cells are placed in
hypertonic saline, water will be drawn out of the cell and the cell will shrink or
crenate. When RBCs placed in isotonic saline (.85%) there is no appreciable change in
the water content of the cell occurs.
Quantitative test
a) Principle: Tubes containing solutions of varying concentrations of saline buffered
to 7.4 Ph were used. Heparinised blood is added to each tube at proportion of 1:100.
After the tubes have been centrifuged to settle all the RBC, the degree of haemolysis
was noted after 24 hours of incubation at room temperature.
b) Stock solution
A stock solution of buffered sodium chloride osmotically equivalent to 10% NaCl is
made up as follows:
NaCl                                 90 g
Na2HPO4 13.65 g
NaH2PO42 H2O           2.43g
Distilled water to      1000ml
The solution was stored in a stoppered bottle for further analysis and can be
maintained for months without deterioration.
Working solution
Working solutions is prepared as 1% solution from 10% of the stock solution,
by diluting in a ratio of 1:10 with distilled water. Then from this 1% solutions
equivalent to 85,0.75,0.65,0.60,0.55,0.50,0.45,0.40,0.35,0.30,0.20 and 0.10 percent
NaCl can be prepared. The serial concentration of saline are prepared by adding saline
and distilled water to twelve test tubes as indicated in the following table
Table – 4. Serial concentration of NaCl with distilled water.
Method
About 0.05 ml of heparinised blood is added to the test tubes with serial
concentration of saline and incubated at room temperature.  0.05 ml control blood
were added to similar set of test tubes. The test tubes were incubated overnight and
then the results were read in the next morning. Normally haemolysis starts at 0.45-
0.50 per cent and complete haemolysis is seen at 0.20 per cent.
Hemosiderinuria
Hemosiderin is an iron containing compound and it is a form in which the body
stores iron. The principle of staining is the so called ‘Prussian blue reaction, in which
ionic iron reacts with acid ferrocyanide to give a blue colour.
About ten ml of urine sample were taken and centrifuged at 1500 rpm for ten
minutes. The supernatant is poured off. Nearly 1-2 drops of the sediment is placed on
glass slide and a smear is made as per the procedure followed earlier. It was allowed
to air dry. Then it was fixed with methyl alcohol. The slide was placed on two parallel
glass rods which are placed above a plastic tray. Then 5 ml of a staining mixture
obtained by mixing equal volumes of 2% potassium ferrocyanide and 2% HCl was
poured over the slide and allowed to stand for 10-15 minutes. Then the slide was air
dried and mounted with DPX. Typically deeply blue stained granules( fig.5&6)
indicate a positive test result.
Hemoglobinuria
Blood or haemoglobin excreted in urine is detected by benzidine test. The
principle is an enzymatic reaction where the haemoglobin peroxidase act on H2O2 to
liberate nascent oxygen. Oxygen oxidises benzidine to a blue coloured compound.
About  2ml of glacial acetic acid was taken , a pinch of Benzedrine powder was
added in a test tube.  Five ml of urine and 1ml of hydrogen peroxide was added to this
test tube. A colour change to blue marks the test as positive.
Coomb’test
DIRECT ANTIGLOBULIN TEST (DAT)
Method
The test tubes were labelled with the respective patients name. About 2-3 drops
of patent’s red cells were placed in the tube and then washed 3 times with saline to
remove all the traces of serum. A drop of coombs serum was added to the tube, and
kept  at room temperature for 5 minutes. Then the contents were centrifuged slowly
for 1 minute.  A drop from the test tube were taken and placed it a glass slide and
covered with the cover slip and the slides were subjected for macroscopic
examination. Agglutination indicates positive result.
Indirect antiglobulin test (IAT)
Method
The pooled ‘o’ cells are obtained from the blood bank and were washed three times in
normal saline. About 5 per cent saline suspension of pooled ‘o’ cells were prepared.
Three test tubes were taken and labelled as T which represents the test serum; PC for
Positive control and NC for negative control. In the tube labelled as ‘T ’ 2 drops of
test  serum was added , in test  tube labelled as PC two drops of Anti-D serum was
added.  One drop of saline is added in the tube labelled as ‘NC’.  In each tube one
drop of 5 % saline suspension of the pooled ‘O’ cells was added. The tubes were
incubated for one hour at 37°C.  Then 2 drops of Coombs serum was added to each
tube and kept  for 5 minutes and then centrifugde at 1,500 RPM for one minute. The
cells are resuspended and examined for agglutination under microscope. Agglutination
in both test and control and no agglutination in negative control indicate a positive
result.
RESULTS AND OBSERVATION
DIAGNOSIS OF HAEMOLYTIC PROCESS USING PERIPHERAL SMEAR
In our study group out of 14 cases 7 were diagnosed as thalassaemia which forms 50%
of our study group. Among the infants one was diagnosed as haemolytic disease of
newborn which constitutes about 7.14% of our study population, 3 were assigned as
post haemolytic and 3 were categorized as others which constitutes about 21.42%
each of the study population.
TABLE . 1 MORPHOLOGICAL  ANALAYSIS OF HAEMOLYTIC ANEMIAS
Diagnosis No. of cases
Thalassaemia 7 (50%)
HDN 1 (7.14%)
Post hemolytic anemia 3 (21.42%)
Others 3 (21.42%)
Total 14
ACUTE LYSIS
In the study group out of 14 cases 1 patient had hemoglobinuria. It constituted about
7.14%.It was a new born female baby which had jaundice inappropriate to the
haemolytic process.
TABLE .2: HAEMOGLOBINURIA POSITIVITY (ACUTE LYSIS)
Total No. of
cases
HBN Positive HBN Negative
14 1(7.14%) 13(92.86%)
CHRONIC HEMOLYSIS (HEMOSIERINURIA AMONG STUDY GROUP)
HEMOSIERINURIA AMONG STUDY GROUP
Among the group studied out of 14 patients 7 were found hemosiderinuria positive
and the remaining 7 were hemosiderinuria negative which constitutes about 50% each
of the studied population. Of the 7 positive cases 6 were thalassaemics and one is
assigned as post haemolytic.
TABLE 3 CHRONIC HAEMOLYSIS
CHART NO.1: HEMOSIERINURIA AMONG STUDY GROUP
Negative
50%
Hemosiderinuria
Hemosiderinuria Positive Negative Total
No. of Cases 7(50%) 7(50%) 14
Positive
50%
TABLE 4:  HAEMOSIDERINURIA POSITIVITY AMONG VARIOUS CASES
Thalassaemia Post haemolytic total
HSDN
positive 6 (42.85) 1(7.14%) 7
CHART NO 4 : HAEMOSIDERINURIA POSITIVITY AMONG VARIOUS CASES
IMMUNE HAEMOLYSIS
Among the study group no case was found to be DCT or ICT positive. So the
percentage of immune hemolytic anemia among study group is zero percentage.
TABLE.5
Total  No. of cases DCTPositive ICT Positive
14 0 0
0
1
2
3
4
5
6
7
8
thalassaemia post haemolytic total
TABLE.6  RED CELL LYSIS (OSMOTIC FRAGILITY TEST))
Total  No. of cases Normal increased Decreased
14 8(57.14%) 1(7.14%) 5(35.71%)
In the study group out of 14 cases 8 had a normal osmotic fragility test. One patient
had increased osmotic fragility and 5 patients had decreased osmotic fragility which
constitutes about 7.14% and 35.71% respectively.
INDEX OF ACUTE HEMOLYSIS
(RETICULOCYTE COUNT)
Among the group studied the reticulocyte count was found increased in 11 patients
i.e. 78.57 % of patients had increased reticulocyte count. One patient had normal and
another two patients had a decreased reticulocyte count which constituted about
7.14% and 14.28% respectively.
TABLE.7: RED CELL LYSIS
Total  No. of cases normal increased decreased
14 1(7.14%) 11 (78.57) 2 (14.28%)
RED CELL INDICES IN VARIOUS HAEMOLYTIC ANEMIAS
The mean values of RBC indices in thalassaemia is as follows: Hb 7.42, MCV 81.3,
MCH 27.74, MCHC 30.7 ,in post hemolytic state is as follows : Hb 4.53,MCV 105.1,
MCH 25.56, MCHC 35.3 and in  the group assigned as others is Hb 11.76 MCV 84.2,
MCH 28.63, MCHC 33.83. In a case of HDN the red cell indices are Hb 15,MCV
103,MCHC34.2 andMCH38.7.
TABLE 8: RED CELL INDICES IN VARIOUS HAEMOLYTIC ANEMIAS
RED CELL INDICES IN HAEMOLYTIC ANEMIA
HgB ( gm/dl) MCV (fl) MCHC (pg/cell) MCH (%)
Thalassaemia 7.42 81.3 30.7 27.74
Posthaemolytic 4.53 105.1 35.3 25.56
HDN 15 103 34.2 38.7
Others 11.76 84.2 33.83 28.63
CHART NO 5: RED CELL INDICES IN VARIOUS HAEMOLYTIC ANEMIAS
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RESULTS OF BIOCHEMICAL PARAMETER OF LYSIS
In our study group among 14 cases bilirubin found elevated in 13 patients and it was
found normal in one patient.
TABLE 9: RESULTS OF BILIRUBIN
TABLE 10:
Intravascular
haemolytic anaemia
Extravascular
haemolytic anaemia
8 (57.14%) 6  (42.85%)
DIAGNOSIS OF HAEMOLYTIC PROCESS USING THE SCREENING PANEL
In our study group out of 14 cases 7 were diagnosed as thalassaemia which forms 50%
of our study group.among the infants one was diagnosed as haemolytic disease of
newborn which constitutes about 7.14% of our study population,3 were assigned as
post haemolytic and 3 were categorized as others which constitutes about 21.42%
each of the study population.
TABLE 11. DISTRIBUTION OF VARIOUS HAEMOLYTIC ANEMIAS
Diagnosis No. of cases
Thalassaemia 7(50%)
HDN 1(7.14%)
Post hemolytic anemia 3(21.42%)
Others 3(21.42%)
Total 14
Total  No. of cases Decreased increased Normal
14 0 13 (92.85%) 1 (7.14%)
CHART NO 10: DISTRIBUTION OF VARIOUS HAEMOLYTIC ANEMIAS
TABLE.12 Efficacy of screening panel
Diagnosis Disease Others statistics
Yes 6 0 P =0.01
No 2 6
Table 11 shows the efficacy of screening panel in diagnosing haemolytic anemias. Of
the 14 cases 6 were already diagnosed,2 were newly diagnosed and  6 were  could not
be  categorized. Fisher’s exact test reveals that the test is statistically significant with a
p value of 0.01.
22%
21%
Distribution of Hemolytic Anemia
50%
7%
Thalassaemia
HDN
Post hemolytic anemia
Others
TABLE.13 Acute Hemolysis
Diagnosis
Results Disease others
Positive 0 1
Negative 11 2
Table 17 shows efficacy of haemoglobinuria in acute haemolysis. Of which 1 came
out to be positive in the others group, rest of them were negative. Fisher’s exact test
reveals that the test was statistically insignificant with a p value of 0.214.
TABLE.14: Chronic Hemolysis
Diagnosis
Results Disease others
Positive 7 0
Negative 2 5
Table 13 shows efficacy of haemosiderinuria in chronic haemolysis. Of the 14
variables 7 denotes positive  in categorized group,2 denotes negative in categorized
group and 5 denotes negative in others group. Fisher’s exact test reveals that the test
was statistically significant with a p value of 0.021.
TABLE 15. Red Cell Lysis
Diagnosis
Disease others
Normal 6 2
Increased 0 1
Decreased 5 0
Table no 14 shows the efficacy of osmotic fragility test. Of the 14 variables 6 denotes
categorized cases with normal OFT,5 denotes categorized cases with decreased OFT,2
denotes  others group with normal OFT and 1 denotes others group with increased
OFT. Pearson chi square test revealed a p value of 0.078. With more number of
samples the efficacy can be better.
TABLE 16. Reticulocyte index
Diagnosis
Disease others
<0.5 1 1
0.5-2.5 1 0
>2.5 9 2
Table no 15 shows the efficacy of reticulocyte count in red cell lysis. Of the 14
variables 1, 1, and 9 denotes decreased, normal and increased reticulocyte count in
categorized group 1, 2, 0 of the others group represent decreased, increased, and
normal reticulocyte count. Pearson chi square test revealed a p value of 0.519. With
more number of samples the efficacy can be better.
TABLE 17 : Biochemical evidence of haemolysis
Diagnosis
Bilirubin Disease others
<1.5 1 0
1.5-3 2 0
>3 8 3
Table no 16 shows the efficacy of level of bilurubin in diagnosing haemolysis. Of the
14 variables 1, 2, and 8 denotes normal, moderate, and severe increase in bilirubin
level in categorized group 0, 0 and 3 of the others group represent normal, moderate
and severe increase bilirubin level. Pearson chi square test revealed a p value of 0.594.
With more number of samples the efficacy can be better.
Discussion
The study was conducted in Tirunelveli medical college hospital, tirunelveli, southern
Tamilnadu, suspected cases of haemolytic anaemia who were referred to the clinical
haematology lab were included in the study. A total number of 14 patients were
subjected to the screening panel.
With regard to clinical features most of the patients presented with moderate to severe
anaemia, icterus, and splenomegaly. Of the 14 patients two newborns presented with
normal haemoglobin range but with other features of haemolysis.
In our study, majority of patients were paediatric i.e. 64% while remaining 36%
constitute adult population .With regard to sex distribution it was equal.
R.H.Deshpande and A.R.Joshi et .al study on haematological profile in haemolytic
anemia 101 in the region of marathwada, Maharastra showed 67.1% were males and
remaining 32.8% were females.
R.H.Deshpande and A.R.Joshi et .al showed  similar pattern of distribution of
haemolytic anemias dominated beta thalassaemia (41.17%) followed by other
haemoglobinopathies. but in their study they included Haemoglobin electrophoresis
which enabled to them to diagnose better of the suspected cases. In our study our vital
tool for diagnosis is peripheral smear. With peripheral smear alone we can be able to
categorise cases as thalassaemia (50%),haemolytic disease of newborn(7.14%) ,post
haemolytic state (21.42%) and the remaining were assigned as others for which no
conclusive clue derived from peripheral smear (table no.1).   In the others group one
case was suspected to be of enzyme defect.
Out of 14 patients one sample was positive for haemoglobinuria and others were
found to be negative (table .2).  haemoglobinuria was positive in a new born. The
baby had severe jaundice with elevated WBC count of 1, 20,800 with a clinical
suspicion of a haematological malignancy. But peripheral smear examination showed
elevated nRBCS revealing an underlying haemolytic process. So the haematological
malignancy was ruled out but it could not be categorised on the basis of screeninig
panel.
Haemosiderinuria was found positive in 50% of cases the rest were found negative
(tab.no.3). Of the positive cases 6 were thalassaemics (42.85%) and one case was
categorised as post haemolytic state. haemosiderinuria was taken as an index of
chronic haemolysis in the present study. Fisher’s exact test was done (table 14).
In our study all our patients were subjected to osmotic fragility test. It was found
normal in 57.14% of cases, increased in 7.14% of cases and decreased in 35.71 % of
cases (table no .6). The case in which it was found increased was categorized on
others because the peripheral smear showed microspherocytes of variable size. With
increased reticulocyte count and elevated bilurubin, decreased MCV, decreased MCH
and a normal MCHC. Coomb’s test was negative. So the case may be an acquired
spherocytosis but could not conclude based on the screening panel. In 6 cases of
thalassaemia the OFT was found decreaed  i.e resistant osmotic lysis.  In rest of the
cases the haemolysis started between 0.4 to 0.5 % concentrations of NaCl. The group
which showed normal include 4 caes of thalassaemia, one categorized as post
haemolytic state and a case of enzyme defect.
All the samples were subjected to reticulocyte count as a part of our screening panel
which showed an increased count in 78.57% of cases (table no.7).the normal  and
decreased count category had moderate anemia,with mild elevation of bilurubin . We
were able to diagnose a case of α-thalassaemia based on studying the smear and the
typical ‘golf ball’ appearing reticulocytes( fig.4) were made out.
in our study by analysising our panel of investigations we were  able to assign 57.14%
of patients are having intravascular haemolysis and 42.85% having extravascular
haemolysis.
Gurpreet, Dhaliwal, et al 102and R. J. Abbott et al.103 showed hyperbilurubinemia is
associated with haemolytic disorders. In  our study group 92.85% of population had
an increased level and 7.14% had a normal level (table no.9). This correlate with other
studies of hyperbilurubinemia and an underlying haemolytic pathology. In a study on
thalassaemias  Amirta panja et al showed  MCV of 50-69fl,MCH of 12-30 pg and Hb
of 7-11 gm .Comparing with  the above study our study showed a MCV of 81.3 which
is slightly higher ,Hb of 7.42 which is similar  to the above study. MCH is 27.74
which is also similar to the above study. The post haemolytic group showed an
average Hb of 4.53gm/dl,mcv of 105.1fland mch of 25.56 pg. the group asssingned as
others showed an average Hb of 11.76,mcv of 84.2 and MCHC of   33.83pg/cell.
Giri et al at boroda (Gujrat) in 1984 and Joshi Anil et al in (1986),
R.H.Deshpande and A.R.Joshi et .al . showed thalassaemias  were the most common
haemoglobinopathy followed by sickle cell anemias. But our study group out of 14
cases 43 % were already diagnosed cases of thalassaemia on follow up we applied our
panel of   tests to test its efficacy. We were able to diagnose a case of alpha
thalassaemia based on our screening panel.  This is lesser than earlier studies like
R.H.Deshpande and A.R.Joshi et .al . But we have not applied any diagnostic tests
like haemoglobin electrophoresis or gel electrophoresis which would have made it
possible for categorising more cases. We were able diagnose a case of HDN using this
screening panel.in 21.42% of cases the predominant feature was microspherocytes
with other parameters like elevated bilirubin and reticulocytes which favoured a post
haemolytic state and further investigations are warranted for accurate diagnosis. The
remaining 21.42% we were able to establish an underlying haemolytic process.
Rao K Uma Maheswara, Manoj Y et al 104 study of Clinico-haematological Profile of
Haemolytic Anaemias in  36 cases ,Andhra Pradesh, India showed Sickle cell
anaemia-7 cases (19.44%), Sickle cell trait- 1 case (2.77%), Sickle cell/beta
thalassemia-12 cases (33.33%), betathalassemia major- 13 cases (36.11%) and beta
thalassemia intermedia 1 case (2.77%). Sickle beta thalassemia and sickle cell
anaemia combinely constitutes 53% of cases followed by beta thalassemia major.
Haemolytic anaemias with enzyme defects and membrane defects were not observed
in this study. Majority of these cases presented with progressive pallor and hepato
splenomegaly. Peripheral blood smear examination showed microcytic hypochromic
anaemia in majority of the cases. All cases were associated with reticulocytosis.
Haemoglobin electrophoresis confirmed the diagnosis.   The clinical presentation,
reticulocyte count and PBF findings are similar to our results. In our study we had
similar distribution dominated by haemoglobinopathies. We were not able to diagnose
membrane defects or enzyme defects with our panel of investigations as like the bove
mentioned study.. In contrast to the above study our work up does not include
haemoglobin electrophoresis.
Kaustubh Chattopadhyay , Romy Biswas et al 105an epidemiological study on the
clinico – hematological  profile of patients with congenital hemolytic  anemia in  a
tertiary care hospital of Kolkata showed the commonest congenital hemolytic anemia
in the present study is HbE Beta Thalassemia (41.1%) followed by Beta Thalassemia
(23.6%) total WBC count, RBC count ,differential WBC count, evaluation of
platelets, Serum total bilirubin, Serum Ferritin and Hb Electrophoresis were done in
this study. The results were similar to our study except Hb Electrophoresis and Serum
Ferritin which will be useful to make a better diagnosis.
This basic screening panel includes simple tests which are time saving and cost
effective. With this panel of investigations we can be able make out whether the
etiology of haemolysis whether acute or chronic or immune mediated. By combining
red cell indices, peripheral amear and reiculocyte count most of the etiology of
haemolytic process can be predicted. Other tests like osmotic fragility test will give
direction to further work up. Ayalew Tefferi et al 98in their study of A Contemporary
Approach to Diagnosis in  Anemia in Adults showed  the significance of
haemosiderinuria  with regards to exravascular and intravascular causes of
haemolysis. In our study 50 % of study group showed hemosiderinuria. The efficacy
of haemosiderinuria in chronic haemolysis as per fisher exact test was 0.021 which
was proved to be a significant index in our panel.
The efficacy of the panel will be better if the samples were received before the
commencement of therapy. The efficacy of the screening panel will be better if the
sample size is large.
SUMMARY
In our study we subjected a group of patients with suspected clinical diagnosis
of haemolytic anemia to a basic panel of investigations.  With peripheral smear
analysis we assigned 50% of cases as Thalassaemias, 21.42% as post haemolysis,
7.14% as haemolytic disease of new born 21.42% as others.
Haemoglobinuria testing in our study group we had found 7.14% were positive
and 92.86% were found negative.  Haemosiderinura was found to be positive in 50%
of cases and negative in 50% of cases. The efficacy of haemosiderinuria testing was
found to more significant. In our study group DCT & ICT were found to negative in
all patients. The osmotic fragility test was found to be increased in 7.14% of cases,
decreased in 35.71% of cases and it was found normal in 57.14% of cases. The
reticulocyte index which is an index of acute haemolysis was found to be increased in
78.57% of cases, decreased in 14.28% of cases and it was normal in 7.14% of cases.
Bilirubin, a biochemical parameter of haemolysis was found elevated in
92.85% of cases and was found normal in 7.14% of cases which proves to be a
significant biochemical index of haemolysis.
We were able to assign 57.14% as intravascular haemolytic anaemia and
42.85% as extravascular haemolytic anaemia.
Over all as a basic screening panel it is efficient in making a diagnosis 50% of
patients were having thalassaemia, 7.14 % of patients were having haemolytic disease
of newborn, 21.42% were diagnosed as post haemolysis and the remaining 21.41% are
assigned as others in whom an underlying haemolytic process was established by
using our panel.  The efficacy of screening panel was significant with a ‘p’ value of
0.01. From this study, 79% of patients having a clinical suspicion of haemolytic
anaemia were diagnosed using basic screening panel of investigations.
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ANNEXURE I
Figure – 4. Golf ball appearance of Reticulocytes  seen in HbH.
Figure – 5. Hemosiderin deposits in urine (Prussian Blue stain).
Figure – 6. Hemosiderin deposits in urine (Prussian blue stain).
Figure – 7. Target cells, microcytes, ovalocytes, nRBCs, and elliptocytes (Leishman
stain).
Figure – 8. Reticulocytes showing bluish thread like material (supravital stain).
Figure – 9. Showing microspherocytes.
ANNEXURE II
PROFORMA
NAME
AGE
SEX
ADDRESS
OCCUPATION
DURATION AND DETAILS OF ILLNESS
SYMPTOMS
 Easy fatiguability
 Frequent falls
 Dizziness
 Tinnitus
 Palpitations
 Abdominal distention
 Symptoms of thyroid disturbances
 Recurrent infections
PAST HISTORY
 Diabetes
 Hypertension
 Coronary artery disease
 Tuberculosis
 Malignancies
 Chronic kidney disease
DRUG HISTORY
PERSONAL HISTORY
 Smoking
 Alcoholism
GENERAL EXAMINATION
 Pallor
 Icterus
 Pedal edema
 Lymphadenopathy
 Clubbing
 Koilonychia
 Glossitis
 Angular stomatitis
 Aphthous ulcers
SYSTEMIC EXAMINATION
CVS
RS
ABDOMEN
CNS
INVESTIGATIONS
 CBC
 ESR
 Stool for occult blood
 Blood urea
 Serum creatinine
 Liver function tests
 Peripheral smear
 Reticulocyte count
 Serum ferritin
 Serum iron
 Total iron binding capacity
 Imaging studies
 Endoscopic studies ( if needed)
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